地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：17754422825
传真：18327026838
邮箱：sales@amyjet.com
艾美捷科技代理ZEUS Scientific 品牌。
ZEUS Scientific及其前身公司SurModics In Vitro Technologies于1979年成立，2007年合并了BioFX公司。ZEUS Scientific公司提供的产品种类丰富，涵盖多个科研和临床领域，主要包括：蛋白稳定剂（protein stabilization reagents）、比色底物及化学发光底物（colorimetric and chemiluminescent substrates）、DNA和蛋白芯片（activated slides for DNA and protein microarrays）和重组自身免疫抗原，以及辅助试剂，如二抗、封闭试剂、终止液等。此外，其产品还涉及分子生物学、细胞生物学、菌学、遗传学、生物化学、蛋白质学、细胞疗法、临床应用等多个领域。具体产品包括但不限于抗真菌素、维生素、氨基酸、核苷酸、脂类、糖类、白三烯、前列腺素、药理活性化合物、类固醇素结合物等生物分子，以及球蛋白、封闭肽、人蛋白和抗原、小鼠蛋白和抗原等多种蛋白质和抗原。
艾美捷科技有限公司代理Kingfisher Biotech公司产品，详见：
http://www.amyjet.com/Index/lists/catid/27/kid/51.html
Kingfisher Biotech致力于兽医学研究和人类疾病的动物模型，涵盖的物种包括：牛、狗、马、鸡、海豚、猫、猪、仓鼠、小鼠、兔子、大鼠、火鸡等等。目前，Kingfisher Biotech的产品线中有查过1200种重组蛋白、多抗、单抗和ELISA试剂盒，能够为全世界动物保健和动物模型客户提供优质的产品。
Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors.
Kingfisher Biotech公司产品涉及的物种包括：
Bovine、Canine、Caprine、Catfish、Chicken、Dolphin、Equine、Feline、Ferret、Guinea Pig、Hamster、Human、Llama、Monkey、Mouse、Ovine、Rabbit、Rat、Salmon、Swine、Turkey、Zebrafish
| 产品列表 |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1675A-025) |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1675A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1676A-100) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1676A-025) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1676A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1676A-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| Cynomolgus Monkey CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1692Y-003) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1644AP-025) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1644AP-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 alpha (IL-1F1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0667B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Human APRIL (TNFSF13) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0292H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1085H-100) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1085H-025) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1085H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1085H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human CCL21 (6Ckine) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1512H-005) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1531H-025) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1531H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1657GP-100) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1657GP-025) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1657GP-005) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1657GP-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0754D-100) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0754D-025) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0754D-005) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0754D-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0085D-100) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0085D-025) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0085D-005) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0085D-500) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0920D-100) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0920D-025) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0920D-005) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0920D-500) |
| Canine IL-25 (IL-17E) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1697D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Catfish IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0439CF-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Llama ACT1 Activation Monoclonal Antibody (clone LH9A) (Kingfisher, CAT#WS0813L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LH7A) (Kingfisher, CAT#WS0812L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LT78A) (Kingfisher, CAT#WS0823L-100) |
| Llama CD2 or CD6 predicted Monoclonal Antibody (clone LH43A) (Kingfisher, CAT#WS0815L-100) |
| Llama CD2 or CD6 Predicted Monoclonal Antibody (clone LT10A) (Kingfisher, CAT#WS0819L-100) |
| Llama CD44 Monoclonal Antibody (clone LT36A) (Kingfisher, CAT#WS0821L-100) |
| Llama CD45 Predicted Monoclonal Antibody (clone LT12A) (Kingfisher, CAT#WS0820L-100) |
| Llama CD5 Predicted Monoclonal Antibody (clone LT3A) (Kingfisher, CAT#WS0817L-100) |
| Llama CD8 Monoclonal Antibody (clone LT5A) (Kingfisher, CAT#WS0818L-100) |
| Llama MHC II Monoclonal Antibody (clone LT1A) (Kingfisher, CAT#WS0816L-100) |
| Llama Pan B cell Monoclonal Antibody (clone LH41A) (Kingfisher, CAT#WS0814L-100) |
| Llama Pan T cell Monoclonal Antibody (clone LT97A) (Kingfisher, CAT#WS0824L-100) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1031Y-100) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1031Y-025) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1031Y-005) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1031Y-500) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1321Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1321Y-025) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1321Y-005) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1321Y-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody (Kingfisher, CAT#KP1669Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1670Y-050) |
| Cynomolgus Monkey IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1671Y-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody (Kingfisher, CAT#KP1694D-100) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1695D-050) |
| Canine BAFF (TNFSF13B) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1696D-003) |
| Canine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0891D-003) |
| Canine Fas Ligand (FasL) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1288D-003) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1647CT-100) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1647CT-025) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1647CT-005) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1647CT-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0665B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Bovine TNF alpha (TNFSF2) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0675B-003) |
| Bovine VEGF-A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0676B-003) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL2 (MCP-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0659B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0003E-100) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0003E-025) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0003E-005) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0003E-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Zebra Finch SCF (Stem Cell Factor) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1579ZN-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0013B-100) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0013B-025) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0013B-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0013B-500) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0311B-100) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0311B-025) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0311B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0311B-500) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技有限公司代理Kingfisher Biotech公司产品，详见：
http://www.amyjet.com/Index/lists/catid/27/kid/51.html
Kingfisher Biotech致力于兽医学研究和人类疾病的动物模型，涵盖的物种包括：牛、狗、马、鸡、海豚、猫、猪、仓鼠、小鼠、兔子、大鼠、火鸡等等。目前，Kingfisher Biotech的产品线中有查过1200种重组蛋白、多抗、单抗和ELISA试剂盒，能够为全世界动物保健和动物模型客户提供优质的产品。
Kingfisher Biotech, Inc. is committed to accelerating basic veterinary research and human disease research done in animal models by developing and commercializing research reagents specific for a variety of species, including bovine, canine, caprine, chicken, dolphin, equine, feline, guinea pig, hamster, human, mouse, ovine, rabbit, rat, swine, and turkey. We will continue to add species as our customer request specific reagents for their research. Currently, we offer over 1200 recombinant proteins, polyclonal antibodies, monoclonal antibodies and ELISA kits for animal health and animal model research. Our products are primarily cytokines, chemokines, interferons, and growth factors.
Kingfisher Biotech公司产品涉及的物种包括：
Bovine、Canine、Caprine、Catfish、Chicken、Dolphin、Equine、Feline、Ferret、Guinea Pig、Hamster、Human、Llama、Monkey、Mouse、Ovine、Rabbit、Rat、Salmon、Swine、Turkey、Zebrafish
| 产品列表 |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1675A-025) |
| Anole IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1675A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1676A-100) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1676A-025) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1676A-005) |
| Anole IGF-2 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1676A-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| Cynomolgus Monkey CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1692Y-003) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1644AP-025) |
| Bee Defensin-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1644AP-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 alpha (IL-1F1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0667B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Human APRIL (TNFSF13) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0292H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1085H-100) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1085H-025) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1085H-005) |
| Human CCL11 (Eotaxin-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1085H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human CCL21 (6Ckine) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1512H-005) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1531H-025) |
| Human CCL7 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1531H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1657GP-100) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1657GP-025) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1657GP-005) |
| Guinea Pig TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1657GP-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0754D-100) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0754D-025) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0754D-005) |
| Canine CXCL10 (IP-10) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0754D-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0085D-100) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0085D-025) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0085D-005) |
| Canine IL-1 beta (IL-1F2) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0085D-500) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0920D-100) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0920D-025) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0920D-005) |
| Canine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0920D-500) |
| Canine IL-25 (IL-17E) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1697D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Catfish IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0439CF-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1482H-025) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1482H-005) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1482H-500) |
| Human CCL2 (MCP-1) (Yeast-derived Recombinant Protein)- 100 micrograms (Kingfisher, CAT#RP1482H-100) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP01528H-025) |
| Human CCL20 (LARC; MIP-3 alpha; Exodus-1) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP01528H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody (Kingfisher, CAT#KP1690Y-100) |
| Cynomolgus Monkey CCL4 (MIP-1 beta) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1691Y-050) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Llama ACT1 Activation Monoclonal Antibody (clone LH9A) (Kingfisher, CAT#WS0813L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LH7A) (Kingfisher, CAT#WS0812L-100) |
| Llama B Cell Subpopulation Monoclonal Antibody (clone LT78A) (Kingfisher, CAT#WS0823L-100) |
| Llama CD2 or CD6 predicted Monoclonal Antibody (clone LH43A) (Kingfisher, CAT#WS0815L-100) |
| Llama CD2 or CD6 Predicted Monoclonal Antibody (clone LT10A) (Kingfisher, CAT#WS0819L-100) |
| Llama CD44 Monoclonal Antibody (clone LT36A) (Kingfisher, CAT#WS0821L-100) |
| Llama CD45 Predicted Monoclonal Antibody (clone LT12A) (Kingfisher, CAT#WS0820L-100) |
| Llama CD5 Predicted Monoclonal Antibody (clone LT3A) (Kingfisher, CAT#WS0817L-100) |
| Llama CD8 Monoclonal Antibody (clone LT5A) (Kingfisher, CAT#WS0818L-100) |
| Llama MHC II Monoclonal Antibody (clone LT1A) (Kingfisher, CAT#WS0816L-100) |
| Llama Pan B cell Monoclonal Antibody (clone LH41A) (Kingfisher, CAT#WS0814L-100) |
| Llama Pan T cell Monoclonal Antibody (clone LT97A) (Kingfisher, CAT#WS0824L-100) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1031Y-100) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1031Y-025) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1031Y-005) |
| Cynomolgus Monkey IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1031Y-500) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1321Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1321Y-025) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1321Y-005) |
| Cynomolgus Monkey IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1321Y-500) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody (Kingfisher, CAT#KP1669Y-100) |
| Cynomolgus Monkey IL-8 (CXCL8) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1670Y-050) |
| Cynomolgus Monkey IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1671Y-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1074Y-100) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1074Y-025) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1074Y-005) |
| Cynomolgus Monkey Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1074Y-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0357H-100) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0357H-025) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0357H-005) |
| Human IL-8 (CXCL8) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0357H-500) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1067H-100) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1067H-025) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1067H-005) |
| Human Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1067H-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Human IL-8 (CXCL8) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1672H-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1010D-100) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1010D-025) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1010D-005) |
| Canine Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1010D-500) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 100 microgrrams (Kingfisher, CAT#RP1322D-100) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 25 microgrrams (Kingfisher, CAT#RP1322D-025) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1322D-005) |
| Canine PDGF-BB (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP1322D-500) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody (Kingfisher, CAT#KP1694D-100) |
| Canine BAFF (TNFSF13B) Polyclonal Antibody - Biotinylated (Kingfisher, CAT#KPB1695D-050) |
| Canine BAFF (TNFSF13B) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1696D-003) |
| Canine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0891D-003) |
| Canine Fas Ligand (FasL) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1288D-003) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0271D-100) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0271D-025) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0271D-005) |
| Canine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0271D-500) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Canine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0677D-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1658AS-100) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1658AS-025) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1658AS-005) |
| Atlantic Salmon TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1658AS-500) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1647CT-100) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1647CT-025) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1647CT-005) |
| Chicken and Turkey TGF-alpha (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1647CT-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1070F-100) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1070F-025) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1070F-005) |
| Feline Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1070F-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine IFN gamma Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0665B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Bovine IL-17A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0673B-003) |
| Bovine IL-2 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1100B-003) |
| Bovine TNF alpha (TNFSF2) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0675B-003) |
| Bovine VEGF-A Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0676B-003) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1073P-025) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1073P-005) |
| Dolphin Leukemia Inhibitory Factor (LIF) (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1073P-500) |
| Dolphin Leukemia Inhibitory Factor (LIF)(Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1073P-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0001B-100) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0001B-025) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0001B-005) |
| Bovine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0001B-500) |
| Bovine PDGF-BB (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP1319B-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL2 (MCP-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0659B-003) |
| Bovine CCL3 (MIP-1 alpha) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1143B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Bovine CD40 Ligand Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1211B-003) |
| Bovine CXCL10 (IP-10) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0662B-003) |
| Bovine CXCL9 (MIG) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0661B-003) |
| Bovine Erythropoietin (EPO) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY1585B-003) |
| Bovine IL-1 Receptor Antagonist (IL-1F3) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0668B-003) |
| Bovine IL-15 Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0672B-003) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0003E-100) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0003E-025) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0003E-005) |
| Equine IL-4 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0003E-500) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0255CT-100) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0255CT-025) |
| Chicken & Turkey IGF-1 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0255CT-005) |
| Zebra Finch SCF (Stem Cell Factor) (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1579ZN-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0013B-100) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0013B-025) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0013B-005) |
| Bovine IFN gamma (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0013B-500) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0002B-100) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0002B-025) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 5 microgrrams (Kingfisher, CAT#RP0002B-005) |
| Bovine IL-13 (Yeast-derived Recombinant Protein) - 500 microgrrams (Kingfisher, CAT#RP0002B-500) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0009B-025) |
| Bovine IL-15 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0009B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0311B-100) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0311B-025) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0311B-005) |
| Bovine IL-16 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0311B-500) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP0056B-100) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0056B-025) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP0056B-005) |
| Bovine IL-17A (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP0056B-500) |
| Bovine/Caprine/Ovine IL-5 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP0139B-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
| Bovine CCL11 (Eotaxin-1) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0951B-003) |
| Bovine CCL4 (MIP-1β) Do-It-Yourself ELISA, ≤10 Plates (Kingfisher, CAT#DIY0660B-003) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1633-025) |
| Canine, Equine, Feline, Ferret, and Swine TGF-alpha (Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1633-005) |
| IGF-1 (Yeast-derived Recombinant Protein) - 100 micrograms (Kingfisher, CAT#RP1330-100) |
| IGF-1 (Yeast-derived Recombinant Protein) - 25 micrograms (Kingfisher, CAT#RP1330-025) |
| IGF-1 (Yeast-derived Recombinant Protein) - 500 micrograms (Kingfisher, CAT#RP1330-500) |
| IGF-1(Yeast-derived Recombinant Protein) - 5 micrograms (Kingfisher, CAT#RP1330-005) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理Berry & Associates全系列修饰核苷酸等
美国 Berry & Associates 公司成立于1989年，提供近200种亚磷酰胺和核苷酸合成用固相交联单体，以及数百种核苷、核苷酸、糖类、荧光标记物、淬灭剂和杂环化合物。
Founded in 1989 with roots in the nucleoside field, Berry & Associates soon moved into the chemistry of nucleic acids, resulting in a current portfolio of nearly 200 phosphoramidites and solid phase-linked monomers for oligonucleotide synthesis as well as hundreds of nucleosides, nucleotides, carbohydrates, spacers, fluorescent markers, quenchers, and heterocycles - all proudly made at our facility just outside of Ann Arbor, Michigan. Although our company is small, the credentials of our highly trained staff of chemists include over 400 publications and 80 patents in synthetic organic and medicinal chemistry. High quality chemicals, timeliness, and personalized service are the hallmarks of Berry & Associates.
Berry & Associates的主要产品包括：
| 产品名称 | 产品编号 | 纯度 | 规格 |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2'-3'-Dideoxyguanosine | PR 3505 | ≥95% | 25 mg; 100 mg |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 2',3'-Dideoxyuridine | PY 7278 | ≥97% | 100 mg; 500 mg |
| 2',3'-Didehydro-2',3'-dideoxyuridine | PY 7279 | ≥97% | 25 mg; 100 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| 2-Amino-2'-deoxyadenosine | PR 3060 | ≥97% | 1 g; 5 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-deoxyadenosine | PR 3080 | ≥95% | 100 mg; 1 g |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-isobutyryl-2'-deoxyadenosine | PR 3130 | ≥95% | 100 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2-(Dimethylaminomethylidene)amino-6-methoxylamino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3670 | ≥95% | 100 mg; 1 g |
| 2-Amino-9-(β-D-2'-deoxyribfuranosyl)purine | PR 3070 | ≥97% | 25 mg; 100 mg |
| 2-Amino-9-(2-O-methyl-β-D-ribofuranosyl)purine | PR 3160 | ≥97% | 100 mg; 250 mg |
| 2-Amino-9-(β-D-ribofuranosy)purine Hemihydrate | PR 3180 | ≥97% | 25 mg; 100 mg |
| 2-(Dimethylaminomethylidene)amino-9-(β-D-2-deoxyribofuranosyl)purine | PR 3680 | ≥97% | 100 mg; 1 g |
| 6-N-Acyl-6-N-methyl-2'-deoxyadenosine | PR 3006 | ≥95% | 25 mg; 100 mg |
| 8-Amino-2'-deoxyadenosine | PR 3115 | ≥97% | 10 mg; 100 mg |
| N6-(6-Aminohexyl)-2'-deoxyadenosine | PR 3120 | ≥90% | 100 mg; 1 g |
| 8-Azido-2'-deoxyadenosine | PR 3125 | ≥97% | 10 mg; 100 mg |
| N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | PR 3230 | ≥95% | 50 mg; 250 mg |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | PR 3260 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| 8-Benzyloxy-2'-deoxyadenosine | PR 3280 | ≥97% | 100 mg; 1 g |
| 8-Bromo-2'-deoxyadenosine | PR 3290 | ≥90% | 2 g; 10 g |
| 8-Bromo-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3320 | ≥95% | 100 mg; 1 g |
| 8-Bromo-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-2'-deoxyadenosine | PR 3340 | ≥97% | 0g (discontinued); |
| 2'-Deoxyadenosine Monohydrate | PR 3445 | ≥97% | 25 g; 100 g |
| 2',3'-Dideoxyadenosine | PR 3495 | ≥95% | 25 mg; 100 mg |
| 2-Fluoro-2'-deoxyadenosine | PR 3496 | ≥97% | 25 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| N6-Methyl-2'-deoxyadenosine | PR 3740 | ≥97% | 100 mg; 1 g |
| 4-Chloro-1-(2-deoxy-β-D-ribofuranosyl)-7-methyl-1H-imidazo[4,5-c]pyridine | PRA 10012 | ≥95% | 10 mg; 50 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| 7-(3-Nitrophenyl)-7-deaza-2'-deoxyadenosine | PRA 10032 | ≥95% | 10 mg; 50 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 8-Allyloxy-2'-deoxyguanosine | PR 3010 | ≥90% | 0Discontinued; |
| 8-Allyloxy-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3015 | ≥90% | 1 g; 10 g |
| 8-Allyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3020 | ≥90% | 1 g; 10 g |
| 5'-Azido-5'-deoxyguanosine | PR 3225 | ≥90% | 5 mg; 10 mg |
| 8-Benzyloxy-N2-isobutyryl-2'-deoxyguanosine | PR 3285 | ≥90% | 1 g; 10 g |
| 8-Bromo-2'-deoxyguanosine | PR 3300 | ≥90% | 1 g; 5 g |
| 8-Bromo-5'-O-(dimethyoxytrityl)-N2-(dimethyl-aminomethylidene)-2'-deoxyguanosine | PR 3310 | ≥97% | 500 mg; 1 g |
| 8-Bromo-N2-(dimethylaminomethylidene)-2'-deoxyguanosine | PR 3330 | ≥90% | 250 mg; 1 g |
| 5'-O-Dimethoxytrityl-N2-(dimethylaminomethylidene)-8-ethenyl-2'-deoxyguanosine | PR 3335 | ≥95% | 100 mg; 1 g |
| 2'-Deoxyguanosine monohydrate | PR 3452 | ≥97% | 10 g; 100 g |
| α-2'-Deoxyguanosine | PR 3455 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-ethyl-2'-deoxyguanosine | PR 3600 | ≥97% | 100 mg; 1 g |
| 3',5'-Di-O-acetyl-2'-deoxyguanosine | PR 3605 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-N2-methyl-2'-deoxy-guanosine | PR 3630 | ≥97% | 100 mg; 1 g |
| N2-Ethyl-2'-deoxyguanosine | PR 3700 | ≥95% | 25 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| N2-Isobutyl-2'-deoxyguanosine | PR 3745 | ≥97% | 10 mg; 100 mg |
| N1-Methyl-2'-deoxyguanosine | PR 3748 | ≥97% | 25 mg; 1 g |
| N2-Methyl-2'-deoxyguanosine | PR 3750 | ≥97% | 25 mg; 100 mg |
| O6-Methyl-2'-deoxyguanosine | PR 3755 | ≥90% | 5 mg; 25 mg |
| 6-Thio-2'-deoxyguanosine | PR 3845 | ≥97% | 10 mg; 100 mg |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3090 | ≥97% | 250 mg; 1 g |
| 2-Amino-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine | PR 3110 | ≥95% | 250 mg; 1 g |
| 2-Amino-N2-O-methyladenosine | PR 3150 | ≥97% | 1 g; 10 g |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 2'-O-Methyladenosine | PR 3734 | ≥97% | 1 g; |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-thiouridine | PY 7575 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-O-methyl-4-(methylithio)uridine | PY 7577 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 5'-O-Acetyl-3'-azido-N2-palmitoyl-2',3'-dideoxy-guanosine | PR 3000 | ≥97% | 25 mg; 250 mg |
| 3'-Azido-N6-benzoyl-2',3'-dideoxyadenosine | PR 3200 | ≥90% | 50 mg; 250 mg |
| 3'-Azido-2',3'-dideoxyadenosine | PR 3210 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-2',3'-dideoxyguanosine | PR 3220 | ≥97% | 10 mg; 25 mg |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| N6-Benzoyl-3'-deoxyadenosine | PR 3240 | ≥97% | 100 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | PR 3250 | ≥97% | 100 mg; 1 g |
| 3'-Deoxyadenosine | PR 3430 | ≥97% | 10 mg; 100 mg |
| 3'-Deoxyguanosine | PR 3460 | ≥97% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-3'-deoxyguanosine | PR 3590 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-3'-deoxyguanosine | PR 3690 | ≥97% | 20 mg; 100 mg |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 5'-O-(Dimethoxytrityl)-5,6-dihydro-2'-deoxyuridine | PY 7230 | ≥97% | 100 mg; |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3040 | ≥97% | 1 g; |
| 2-Amino-6-chloro-9-(3,5-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3045 | ≥95% | 1 g; |
| 2-Amino-6-chloro-9-(β-D-ribofuranosyl)purine | PR 3050 | ≥95% | 5 g; 25 g |
| 6-Chloro-9-(β-D-2-deoxyribofuranosyl)purine | PR 3370 | ≥97% | 100 mg; 1 g |
| 6-Chloro-9-(3,5-O-di-(p-toluoyl)-β-D-2-deoxyribofuranosyl)purine | PR 3380 | ≥90% | 100 mg; 1 g |
| 6-Chloro-9-(5-O-dimethoxytrityl-β-D-2-deoxyribofuranosyl)purine | PR 3390 | ≥97% | 0 g; |
| 6-Chloro-9-(β-D-ribofuranosyl)purine | PR 3400 | ≥97% | 5 g; 10 g |
| Adenosine | PR 3005 | ≥97% | 100 g; 1 kg |
| 8-Methyladenosine | PR 3007 | ≥95% | 25 mg; 100 mg |
| Vidarabine | PR 3008 | ≥97% | 1 g; 5 g |
| 2-Aminoadenosine (2,6-Diaminopurine riboside) | PR 3030 | ≥97% | 2 g; 10 g |
| N1-Methyladenosine hydroiodide | PR 3032 | ≥95% | 100 mg; 1 g |
| 2-Methyladenosine | PR 3035 | ≥97% | 10 mg; 25 mg |
| 5'-Chloro-5'-deoxyadenosine | PR 3360 | ≥97% | 100 mg; 1 g |
| N6-Methyladenosine | PR 3732 | ≥97% | 100 mg; 1 g |
| N6-Methyl-2'-O-Methyladenosine | PR 3733 | ≥97% | 50 mg; 100 mg |
| 3-Deaza-3-methyl-2'-deoxyadenosine | PRA 10013 | ≥97% | 10 mg; 25 mg |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 2-Amino-4-chloro-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10000 | ≥97% | 100 mg; 1 g |
| 2-Amino-4-methoxy-7-(β-D-2-deoxyribofuranosyl)pyrrolo[2,3-d]pyrimidine | PRA 10005 | ≥97% | 500 mg; 1 g |
| 4-Chloro-1-(β-D-2-deoxyribofuranosyl)imidazo[4,5-C]pyridine | PRA 10006 | ≥90% | 25 mg; 100 mg |
| 8-Azaadenosine | PRA 10007 | ≥97% | 20 mg; |
| 8-Aza-7-deaza-2'-deoxyadenosine (4-Amino-1-(2-deoxyribofuranosyl)pyrazolo[3,4-d]-pyrimidine) | PRA 10008 | ≥95% | 10 mg; 100 mg |
| 4-Chloro-1-(3,5-di-O-toluoyl-2-deoxy-β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine | PRA 10009 | ≥95% | 100 mg; 1 g |
| N6-Benzoyl-7-deaza-2'-deoxyadenosine | PRA 10010 | ≥97% | 100 mg; 1 g |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; 1 g |
| 5'-O-Dimethoxytrityl-N6-(N,N-dimethylaminomethylene)-8-aza-7-deaza-2'-deoxyadenosine | PRA 10019 | ≥97% | 500 mg; 1 g |
| N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | PRA 10020 | ≥97% | 100 mg; 1 g |
| 3-Deaza-2'-deoxyadenosine | PRA 10025 | ≥97% | 25 mg; 100 mg |
| 7-Deaza-2'-deoxyadenosine | PRA 10030 | ≥97% | 100 mg; 1 g |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; 100 mg |
| 5-Iodo-2'-deoxytubercidin | PRA 10036 | ≥95% | 10 mg; 50 mg |
| 7-Deaza-2'-deoxyguanosine | PRA 10040 | ≥97% | 100 mg; 1 g |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 7-Deaza-2'-deoxyxanthosine | PRA 10050 | ≥97% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-7-deaza-2'-deoxyxanthosine | PRA 10055 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-N2-(dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10100 | ≥97% | 100 mg; 1 g |
| N2-(Dimethylaminomethylidene)-7-deaza-2'-deoxyguanosine | PRA 10110 | ≥97% | 100 mg; 1 g |
| Sangivamycin | PRA 10140 | ≥97% | 10 mg; 25 mg |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; 100 mg |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| dNaM | FC 8110 | ≥97% | 25 mg; 100 mg |
| 9-Deaza-2'-deoxyguanosine | PRA 10120 | ≥97% | 10 mg; 100 mg |
| 9-Deazaguanosine | PRA 10130 | ≥97% | 10 mg; 100 mg |
| 2-Chloro-6-(β-D-2-deoxyribofuranosyl)-3,5-diaminopyrazine | PYA 11000 | ≥97% | 10 mg; 25 mg |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| 2'-Deoxypseudoisocytidine | PYA 11005 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudouridine | PYA 11010 | Purity: ≥97% | 25 mg; |
| 5'-O-(Dimethoxytrityl)-N-(dimethylamino) methylidene-2'-deoxypseudoisocytidine | PYA 11035 | Purity: ≥97% | 50 mg; 100 mg |
| 1,3-Dimethyl-2'-deoxypseudouridine | PYA 11040 | ≥97% | 10 mg; 100 mg |
| 1,3-Dimethylpseudouridine | PYA 11050 | ≥97% | 10 mg; 50 mg |
| N1-Methylpseudouridine | PYA 11052 | ≥95% | 10 mg; 50 mg |
| N3-Methylpseudouridine | PYA 11054 | ≥97% | 10 mg; 25 mg |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Pseudoisocytidine hydrochloride | PYA 11060 | ≥97% | 10 mg; 100 mg |
| Pseudothymidine | PYA 11070 | ≥97% | 10 mg; 100 mg |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; 50 mg |
| 3'-O-(t-Butyldimethylsilyl)-5'-oxo-2'-deoxy-8,5'-cycloadenosine | PR 3350 | ≥97% | 10 mg; |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-Deoxy-8,5'-cycloadenosine | PR 3440 | ≥97% | 10 mg; 100 mg |
| 2',5'-Dideoxy-8,5'-cycloadenosine | PR 3500 | ≥97% | 10 mg; |
| 2',3'-O-Isopropylidene-5'-oxo-8,5'-cycloadenosine | PR 3730 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-8,5'-cycloadenosine | PR 3800 | ≥97% | 10 mg; 100 mg |
| 5'-Oxo-2'-deoxy-8,5'-cycloadenosine | PR 3810 | ≥97% | 10 mg; |
| N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7010 | ≥95% | 0 g DISCONTINUED; |
| N4-Acetyl-5'-methyl-2'-O-methylcytidine | PY 7020 | ≥97% | 0 g DISCONTINUED; |
| N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | PY 7054 | ≥97% | 25 mg; 100 mg |
| N4-Benzoyl-3'-deoxycytidine | PY 7080 | ≥97% | 20 mg; 100 mg |
| N4-Benzoyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | PY 7100 | ≥95% | 100 mg; 1 g |
| N4-Benzoyl-2'-O-methylcytidine | PY 7110 | ≥97% | 500 mg; 1 g |
| 5-Bromo-2'-deoxycytidine | PY 7115 | ≥97% | 1 g; 10 g |
| Cytidine | PY 7215 | ≥97% | 50 g; 500 g |
| 2'-Deoxycytidine | PY 7216 | ≥97% | 10 g; 50 g |
| 2'-Deoxycytidine Hydrochloride | PY 7217 | ≥97% | 5 g; 50 g |
| 5'-Azido-2',5'-dideoxycytidine | PY 7219 | ≥97% | 25 mg; 100 mg |
| 3'-Deoxycytidine | PY 7220 | ≥97% | 20 mg; 100 mg |
| N4-Ethyl-2'-deoxycytidine | PY 7245 | ≥97% | 100 mg; 250 mg |
| 5-Methyl-2'-deoxyisocytidine | PY 7255 | ≥95% | 500 mg; 1 g |
| 6-(β-D-2-Deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7270 | ≥97% | 20 mg; 50 mg |
| 2',3'-Dideoxycytidine | PY 7325 | ≥95% | 50 mg; 100 mg |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-iodo-2'-O-methylcytidine | PY 7350 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | PY 7360 | ≥97% | 0 DISCONTINUED; |
| N4-(Diisobutylaminomethylidene)-5-iodo-2'-O-methylcytidine | PY 7370 | ≥97% | 0 DISCONTINUED; |
| 6-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido-[4,5-c][1,2]oxazin-7-one | PY 7380 | ≥97% | 50 mg; |
| N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-deoxycytidine | PY 7400 | ≥97% | 100 mg; 500 mg |
| 5-O-(Dimethoxytrityl)-N4-dimethylaminomethylidene-5-iodo-2'-deoxycytidine | PY 7410 | ≥97% | 100 mg; |
| 6-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8H-pyrimido[4,5-c][1,2]oxazin-7-one | PY 7540 | ≥95% | 250 mg; 500 mg |
| Cytidin-5-yl-methanesulfonate sodium salt hydrate | PY 7586 | ≥95% | 50 mg; 100 mg |
| 5-[(2-Cyanoethoxy)methyl]-2'-deoxycytidine | PY 7587 | ≥97% | 10 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxycytidine | PY 7588 | ≥97% | 50 mg; 100 mg |
| 5-Formyl-2'-deoxycytidine | PY 7589 | ≥97% | 5 mg; 10 mg |
| 5-Carboethoxy-2'-deoxycytidine | PY 7592 | ≥95% | 25 mg; 100 mg |
| 2'-Deoxycytidine-5-carboxylic acid, sodium salt | PY 7593 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxymethylcytidine | PY 7596 | ≥97% | 50 mg; 100 mg |
| Cytidine-5-carboxylic acid, sodium salt | PY 7598 | ≥97% | 10 mg; 50 mg |
| 5-Formylcytidine | PY 7599 | ≥97% | 5 mg; 10 mg |
| 5-Iodo-2'-deoxycytidine | PY 7607 | ≥97% | 2 g; 10 g |
| 5-Iodocytidine | PY 7609 | ≥97% | 5 g; |
| 5-Iodo-2'-O-methylcytidine | PY 7620 | ≥90% | 20 mg; 100 mg |
| 5-Methyl-2'-deoxycytidine Hydrochloride | PY 7635 | ≥97% | 0.25 g; 1 g |
| 2'-O-Methylcytidine | PY 7636 | ≥97% | 1 g; 5 g |
| 5-Methylcytidine | PY 7637 | ≥97% | 1 g; 5 g |
| N4-Methylcytidine | PY 7638 | ≥97% | 25 mg; 100 mg |
| 5-Methyl-2'-O-methylcytidine | PY 7640 | ≥97% | 100 mg; 500 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| 5-(1-Propynyl)-2'-O-methylcytidine | PY 7660 | ≥95% | 10 mg; 50 mg |
| 5-(1-Propynyl)-2'-deoxycytidine | PY 7700 | ≥90% | 5 mg; 10 mg |
| 2-Thiocytidine | PY 7721 | ≥97% | 10 mg; 100 mg |
| 2-Thio-2'-deoxycytidine | PY 7723 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| N6-Benzoyl-8-oxo-2'-deoxyadenosine | PR 3270 | ≥97% | 100 mg; 1 g |
| (5'S)-8,5'-Cycloadenosine | PR 3410 | ≥97% | 10 mg; 100 mg |
| (5'S)-2'-Deoxy-8,5'-cycloadenosine | PR 3420 | ≥97% | 10 mg; |
| 5'-O-(Dimethoxytrityl)-8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3610 | ≥97% | 100 mg; 1 g |
| 8-Oxo-2'-deoxyadenosine | PR 3705 | ≥95% | 25 mg; 250 mg |
| 8-Oxo-2'-deoxyguanosine | PR 3710 | ≥97% | 25 mg; 250 mg |
| 8-Oxo-N2-isobutyryl-2'-deoxyguanosine | PR 3720 | ≥90% | 100 mg; 1 g |
| 8-Hydroxyguanosine | PR 3795 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 5-Aza-2'-deoxycytidine | PY 7105 | ≥95% | 25 mg; 100 mg |
| 5,6-Dihydro-5-aza-2'-deoxycytidine | PY 7106 | ≥97% | 25 mg; 100 mg |
| 5,6-Dihydro-2'-deoxyuridine | PY 7330 | ≥97% | 100 mg; |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| 5-Hydroxy-2'-deoxycytidine | PY 7595 | ≥95% | 25 mg; 250 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 6-Methylcytidine | PY 7641 | ≥97% | 10 mg; 25 mg |
| Nap-dU | PY 7735 | ≥97% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 3,N4-Etheno-2'-deoxycytidine | PYA 11130 | ≥97% | 100 mg; 500 mg |
| Pyrrolo-dC | PYA 11090 | ≥95% | 10 mg; 100 mg |
| 6-Methyl-3-(β-D-2-ribofuranosyl)pyrrolo[2,3-d]pyrimidin-2-one | PYA 11092 | ≥97% | 10 mg; 100 mg |
| 3-(5'-O-Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-6-methylpyrrolo[2,3-d]pyrimidin-2-one | PYA 11095 | ≥95% | 100 mg; 1 g |
| 3-(2'-Deoxy-β-D-2-ribofuranosyl)pyrido[2,3-d]pyrimidine-2,7(8H)-dione | PYA 11100 | ≥95% | 10 mg; 100 mg |
| 8-18O-Hydroxyguanosine | IOPR 3795 | ≥95% | 2 mg; 5 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| 5'-O-Dimethoxytrityl-N2-(trifluoroacetamido)hexyl-2'-deoxyguanosine | PR 3701 | ≥95% | 25 mg; 100 mg |
| N2-Dimethylguanosine | PR 3702 | ≥97% | 10 mg; 100 mg |
| Guanosine | PR 3703 | ≥97% | 100 g; 500 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| O6-Methylguanosine | PR 3757 | ≥97% | 25 mg; 100 mg |
| 2'-O-Methylguanosine | PR 3760 | ≥97% | 1 g; 10 g |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 8-Bromoguanosine | PR 3796 | ≥97% | 0 g; |
| 8-Benzyloxyguanosine | PR 3797 | ≥95% | 100 mg; 1 g |
| 7-Methyl-7-deaza-2'deoxyguanosine | PRA 10042 | ≥97% | 10 mg; 50 mg |
| 7-Deazaguanosine | PRA 10045 | ≥97% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 2'-Deoxypseudoguanosine | PRA 10103 | ≥97% | 10 mg; 50 mg |
| 2'-Deoxypseudoisoguanosine | PRA 10104 | ≥97% | 10 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-5-nitroindole | PRA 10060 | ≥97% | 100 mg; 1 g |
| 1-(β-D-2-Deoxyribofuranosyl)-4-methylindole | PRA 10070 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-4-methylindole | PRA 10080 | ≥97% | 0 g; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-5-nitroindole | PRA 10090 | ≥97% | 100 mg; 1 g |
| 2'-Deoxy-4-desmethylwyosine | PR 3450 | ≥95% | 100 mg; 500 mg |
| 2'-Deoxyinosine | PR 3463 | ≥97% | 10 g; 100 g |
| 5'-Azido-2',5'-dideoxyinosine | PR 3464 | ≥97% | 5 mg; 25 mg |
| 3',5'-Di-O-acetyl-2'-deoxyinosine | PR 3480 | ≥97% | 1 g; |
| 3',5'-Di-O-acetyl-O6-phenyl-2'-deoxyinosine | PR 3490 | ≥90% | 1 g; |
| 5'-O-(Dimethoxytrityl)-2'-O-methylinosine | PR 3640 | ≥97% | 1 g; |
| 5'-O-(Dimethoxytrityl)-O6-phenyl-2'-deoxyinosine | PR 3660 | ≥97% | 100 mg; 1 g |
| Inosine | PR 3725 | ≥97% | 100 g; 500 g |
| 2',3'-Dideoxyinosine | PR 3727 | ≥97% | 100 mg; 1 g |
| 2'-O-Methylinosine | PR 3770 | ≥97% | 500 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| O6-Phenyl-2'-deoxyinosine | PR 3840 | ≥97% | 100 mg; 1 g |
| 2-Fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3842 | ≥97% | 25 mg; |
| 5'-O-Dimethoxytrityl-2-fluoro-6-O-(2-(4-nitrophenyl)ethyl)-2'-deoxyinosine | PR 3843 | ≥90% | 25 mg; 100 mg |
| 2'-Deoxyisoguanosine | PR 3465 | ≥97% | 10 mg; 100 mg |
| N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | PR 3510 | ≥90% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3520 | ≥95% | 100 mg; 1 g |
| N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | PR 3530 | ≥90% | 100 mg; 1 g |
| Isoguanosine | PR 3735 | ≥97% | 10 mg; 50 mg |
| d5SICS | FC 8120 | ≥97% | 25 mg; 100 mg |
| AICA Riboside (AICAR) | MN 20001 | ≥97% | 0 g (DISCONTINUED); |
| 2',3'-Di-O-methyladenosine | PR 3540 | ≥97% | 100 mg; 1 g |
| 2,6-Bis-O-[2-(4-nitrophenyl)ethyl]-2'-deoxyxanthosine | PR 3692 | ≥95% | 10 mg; 100 mg |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; 100 mg |
| 8-Aza-7-deaza-2'-deoxyguanosine | PRA 10170 | ≥95% | 10 mg; 100 mg |
| 6-Amino-2-(2-deoxy-β-D-ribofuranosyl)-2,5-dihydro-4H-pyrazolo-[3,4-d]-pyrimidin-4-one | PRA 10175 | ≥95% | 10 mg; 100 mg |
| 3'-Deoxy-3',4'-didehydrocytidine | PY 7790 | ≥95% | 10 mg; 25 mg |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| tC Nucleoside | PYA 11110 | ≥97% | 50 mg; 100 mg |
| tCnitro Nucleoside | PYA 11115 | ≥95% | 5 mg; 25 mg |
| 2'-Deoxynebularine | PR 3470 | Purity: ≥97% | 100 mg; 1 g |
| 7-Methylinosine | PR 3780 | ≥95% | 100 mg; 250 mg |
| 7-Methyl-6-thioguanosine | PR 3790 | ≥75% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-3-nitropyrrole | PYA 11020 | ≥97% | 50 mg; |
| 1-(5-O-(Dimethoxytrityl)-β-D-2-deoxyribofuranosyl)-3-nitropyrrole | PYA 11030 | ≥95% | 100 mg; |
| Showdomycin | PYA 11056 | ≥97% | 10 mg; |
| Formycin A | PYA 11001 | ≥97% | 10 mg; |
| Formycin B | PYA 11002 | ≥97% | 10 mg; |
| Pseudouridine | PYA 11080 | ≥97% | 10 mg; |
| Pyrazofurin | PYA 11004 | ≥97% | 10 mg; |
| Toyocamycin | PRA 10150 | ≥97% | 10 mg; |
| 7-Deazaadenosine (tubercidin) | PRA 10035 | ≥97% | 10 mg; |
| Allopurinol riboside | PRA 10011 | ≥97% | 25 mg; |
| 5-Iodotubercidin | PRA 10095 | ≥90% | 5 mg; |
| Triciribine | PRA 10160 | ≥97% | 10 mg; |
| Tricyclic Nucleoside Phosphate | PRA 10162 | ≥95% | 10 mg; |
| 5-Amino-3-β-D-ribofuranosylthiazolo[4,5-d]pyrimidin-2,7(3H,6H)-dione | PRA 10047 | ≥97% | 10 mg; |
| 5'-Amino-5'-deoxythymidine | PY 7030 | ≥97% | 25 mg; 50 mg |
| O2,5'-Anhydrothymidine | PY 7060 | ≥95% | 500 mg; 1 g |
| 3'-Azido-3'-deoxythymidine (AZT) | PY 7065 | ≥97% | 500 mg; 1 g |
| 5'-Azido-5'-deoxythymidine | PY 7070 | ≥97% | 25 mg; 100 mg |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| 3'-O-(t-Butyldimethylsilyl)-5'-deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7120 | ≥97% | 1 g; |
| 3'-O-(t-Butyldimethylsilyl)thymidine | PY 7130 | ≥95% | 500 mg; 1 g |
| 5'-O-(t-Butyldimethylsilyl)thymidine | PY 7140 | ≥97% | 5 g; 10 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)thymidine | PY 7150 | ≥97% | 1 g; 5 g |
| 3',5'-bis-O-(t-Butyldimethylsilyl)-O4-(2,4,6-triisopropylphenylsulfonyl)thymidine | PY 7160 | ≥95% | 100 mg; 500 mg |
| S4-(2-Cyanoethyl)-5'-O-(dimethoxytrityl)-4-thiothymidine | PY 7200 | ≥95% | 10 mg; 100 mg |
| S4-(2-Cyanoethyl)-4-thiothymidine | PY 7210 | ≥95% | 10 mg; 100 mg |
| 5'-Deoxy-5'-(1,3-diphenyl-2-imidazolidinyl)thymidine | PY 7250 | ≥97% | 1 g; |
| 3'-Deoxythymidine | PY 7277 | ≥95% | 50 mg; 100 mg |
| 1-(3,5-Di-O-acetyl-β-D-deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)-5-methylpyrmidin-2-one | PY 7315 | ≥90% | 1 g; 10 g |
| 2',3'-Didehydro-3'-deoxythymidine | PY 7328 | ≥95% | 10 mg; 100 mg |
| (5S)-5,6-Dihydrothymidine | PY 7340 | ≥97% | 20 mg; 100 mg |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| (5S)-5'-O-(Dimethoxytrityl)-5,6-dihydrothymidine | PY 7390 | ≥97% | 100 mg; |
| 5'-O-(Dimethoxytrityl)-N3/O4-(toluoyl)-2-thiothymidine | PY 7510 | ≥97% | 50 mg; 100 mg |
| 2-O-Ethylthymidine | PY 7561 | ≥97% | 500 mg; 1 g |
| 5'-Iodo-5'-deoxythymidine | PY 7610 | ≥97% | 250 mg; 1 g |
| 5'-O-Methylthymidine | PY 7680 | ≥95% | 50 mg; 100 mg |
| 2-Thiothymidine | PY 7725 | ≥95% | 20 mg; 100 mg |
| Thymidine | PY 7727 | ≥97% | 25 g; 250 g |
| 5'-O-(p-Toluenesulfonyl)thymidine | PY 7740 | ≥97% | 5 g; |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5'-Trifluoroacetamido-5'-deoxythymidine | PY 7750 | ≥97% | 50 mg; |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 6-Azathymidine | PYA 11058 | ≥95% | 25 mg; 100 mg |
| NPOM-Caged-dT CEP | BA 0317 | ≥95% | 100 µmol; 0.25 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 3'-Azido-3'-deoxy-5'-O-methylthymidine | PY 7075 | ≥97% | 0 g DISCONTINUED; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| (5S,6R)-5',6'-Cyclo-5'-deoxy-5,6-dihydrothymidine | PY 7345 | ≥95% | 10 mg; 25 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 3-(2-Cyanoethyl)thymidine | PY 7742 | ≥95% | 10 mg; 25 mg |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| NPOM-Caged deoxythymidine | PY 7795 | ≥97% | 25 mg; 100 mg |
| 6-Methyl-3-(β-D-2-deoxyribofuranosyl)furano-[2,3-d]pyrimidin-2-one | PYA 11055 | ≥97% | 5 mg; 25 mg |
| 5-Ethynyl uridine CEP | BA 0353 | ≥90% | 100 µmol; 0.25 g |
| 2'-O-Acetyl-5'-O-benzoyl-5-methyl-3'-deoxyuridine | PY 7000 | ≥97% | 500 mg; 1 g |
| 5-[N-(2-Aminoethyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7040 | ≥97% | 100 mg; 1 g |
| 5-[N-(6-Aminohexyl)-3-(E)-acrylamido]-5'-O-(dimethoxytrityl)-2'-deoxyuridine | PY 7050 | ≥90% | 100 mg; 1 g |
| 5-(Furan-2-yl)-2'-deoxyuridine | PY 7053 | ≥97% | 25 mg; 100 mg |
| 1-(β-D-2-Deoxyribofuranosyl)-4-(1,2,4-triazol-1-yl)pyrimidin-2-one | PY 7055 | ≥97% | 20 mg; 100 mg |
| 5-Bromo-2'-deoxyuridine | PY 7117 | ≥97% | 10 g; 25 g |
| 5-Bromouridine | PY 7118 | ≥95% | 5 g; |
| (E)-5-(2-Carbomethoxyvinyl)-2'-deoxyuridine | PY 7170 | ≥97% | 1 g; |
| (E)-5-(2-Carbomethoxyvinyl)uridine | PY 7172 | ≥97% | 25 mg; 250 mg |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine | PY 7180 | ≥97% | 500 mg; 1 g |
| (E)-5-(2-Carboxyvinyl)uridine | PY 7185 | ≥97% | 1 g; |
| (E)-5-(2-Carboxyvinyl)-2'-deoxyuridine N-Hydroxysuccinimide Ester | PY 7190 | ≥97% | 100 mg; 1 g |
| S4-(2-Cyanoethyl)-4-thio-2'-deoxyuridine | PY 7212 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-3'-deoxyuridine | PY 7240 | ≥95% | 25 mg; 100 mg |
| 5-Methyl-3'-deoxyuridine | PY 7260 | ≥95% | 20 mg; 50 mg |
| 2'-Deoxyuridine | PY 7275 | ≥97% | 25 g; 100 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-deoxyuridine | PY 7280 | ≥95% | 100 mg; 500 mg |
| 3'-Azido-2',3'-dideoxy-5-bromouridine | PY 7286 | ≥97% | 10 mg; 50 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7290 | ≥95% | 500 mg; 1 g |
| 3',5'-Di-O-acetyl-5-fluoro-2'-O-methyluridine | PY 7300 | ≥97% | 50 mg; 250 mg |
| 3',5'-Di-O-acetyl-5-fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7310 | ≥97% | 20 mg; 50 mg |
| 3',5'-Di-O-benzoyl-5-fluoro-2'-O-methyluridine | PY 7320 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-fluoro-2'-O-methyluridine | PY 7420 | ≥95% | 100 mg; 500 mg |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-deoxyuridine | PY 7450 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-iodo-2'-O-methyluridine | PY 7460 | ≥97% | 50 mg; 100 mg |
| 5-Methoxymethyl-2'-deoxyuridine | PY 7465 | ≥95% | 10 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-methyl-2'-O-methyluridine | PY 7470 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-2'-O-methyluridine | PY 7480 | ≥97% | 500 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-deoxyuridine | PY 7490 | ≥95% | 50 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine | PY 7500 | ≥95% | 25 mg; 100 mg |
| 5'-O-(Dimethoxytrityl)-5-[N-(2-(trifluoroacetamido)ethyl)-3-(E)acrylamido]-2'-deoxyuridine | PY 7520 | ≥97% | 100 mg; 1 g |
| 5'-O-(Dimethoxytrityl)-5-[N-(6-(trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7530 | ≥97% | 100 mg; 1 g |
| 1-(3,5-Di-O-(p-toluoyl)-β-D-2-deoxyribofuranosyl)-5-(2-(phthalimidooxy)ethyl)-4-(1,2,4-triazol-1-yl)-lH-pyrimidin-2-one | PY 7550 | ≥95% | 100 mg; 1 g |
| 3',5'-Di-O-(p-toluoyl)-5-(2-hydroxyethyl)-2'-deoxyuridine | PY 7560 | ≥95% | 500 mg; 1 g |
| 5-Ethynyl-2'-deoxyuridine | PY 7562 | ≥97% | 25 mg; 100 mg |
| 5-Ethynyl uridine | PY 7563 | ≥97% | 10 mg; 100 mg |
| 5-Fluoro-2'-deoxyuridine | PY 7565 | ≥97% | 100 mg; 1 g |
| 5-Fluoro-2'-O-methyluridine | PY 7570 | ≥97% | 50 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-deoxyuridine | PY 7580 | ≥97% | 25 mg; 100 mg |
| 5-Fluoro-O4-(2,4,6-trimethylphenyl)-2'-O-methyluridine | PY 7590 | ≥95% | 25 mg; 100 mg |
| 5-Hydroxy-2'-deoxyuridine | PY 7597 | ≥95% | 25 mg; 250 mg |
| 5-(2-Hydroxyethyl)-2'-deoxyuridine | PY 7600 | ≥95% | 25 mg; 50 mg |
| 5-Acetoxymethyl-2'-deoxyuridine | PY 7604 | ≥97% | 25 mg; 100 mg |
| 5-Hydroxymethyl-2'-deoxyuridine | PY 7605 | ≥95% | 25 mg; 250 mg |
| 2'-Fluoro-5'-iodo deoxyuridine | PY 7612 | ≥95% | 100 mg; |
| 5-Iodo-2'-deoxyuridine | PY 7615 | ≥97% | 10 g; 25 g |
| 5-Iodo-2'-O-methyluridine | PY 7630 | ≥97% | 100 mg; 1 g |
| 5-Iodouridine | PY 7632 | ≥95% | 5 g; 25 g |
| 5-Methyl-2'-O-methyluridine | PY 7650 | ≥97% | 100 mg; 1 g |
| 5-(1-Propynyl)-2'-O-methyluridine | PY 7670 | ≥97% | 10 mg; 25 mg |
| 2'-O-Methyluridine | PY 7690 | ≥97% | 5 g; |
| 3-Methyluridine | PY 7694 | ≥97% | 25 mg; 100 mg |
| 5-Methyluridine | PY 7695 | ≥97% | 200 mg; 1 g |
| 5-(1-Propynyl)-2'-deoxyuridine | PY 7710 | ≥97% | 100 mg; 1 g |
| 5-(Propargyloxy)-2'-deoxyuridine | PY 7712 | ≥95% | 10 mg; 100 mg |
| Zebularine | PY 7715 | ≥97% | 10 mg; 25 mg |
| 3',5'-O-(1,1,3,3-Tetraisopropyl-1,3-disiloxanediyl)-2'-deoxyuridine | PY 7720 | ≥90% | 500 mg; 1 g |
| 2-Thiouridine | PY 7724 | ≥97% | 25 mg; 100 mg |
| 5'-O-(p-Toluenesulfonyl)-2'-deoxyuridine | PY 7730 | ≥97% | 1 g; 5 g |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2’-deoxyuridine | PY 7754 | ≥95% | 100 mg; 1 g |
| 5-[3-(Trifluoroacetamido)-1-(E)-propenyl]uridine | PY 7758 | ≥97% | 100 mg; 1 g |
| 5-[N(2-(Trifluoroacetamido)ethyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7760 | ≥90% | 100 mg; 1 g |
| 5-[N(6-(Trifluoroacetamido)hexyl)-3-(E)-acrylamido]-2'-deoxyuridine | PY 7770 | ≥95% | 100 mg; 1 g |
| 5-[N-(6-(Trifluoracetamido)hexyl)-(E)-acrylamido]uridine | PY 7775 | ≥97% | 100 mg; 1 g |
| Uridine | PY 7780 | ≥97% | 100 g; 500 g |
| 2'3'-O-Isopropylidene uridine | PY 7781 | ≥97% | 5 g; 25 g |
| 5-Hydroxymethyl uridine | PY 7782 | ≥97% | 50 mg; 100 mg |
| 5-Methoxyuridine | PY 7783 | ≥97% | 10 mg; 50 mg |
| 6-Aza-2'-deoxyuridine | PYA 11057 | ≥95% | 50 mg; 100 mg |
" data-original="http://oz.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Berry & Associates全系列修饰核苷酸"> 艾美捷科技代理Berry & Associates全系列修饰核苷酸
<艾美捷科技代理Gene Tools品牌
Gene Tools是一家生产和销售Morpholino Anti-sense oligos（反义寡核苷酸)的公司，其产品专门用于基因调控的科学研究和药物开发。Gene Tools公司由多位资深科学家组成，为全球客户提供免费的技术咨询和Morpholino 序列设计服务。 Morpholino作为基因调控研究的最佳工具，已被广泛用于：阻断靶mRNA 翻译 (下调基因）；诱导RNA选择性剪接 (下调或上调基因）；阻断 miRNA；阻断病毒 RNA；阻断 non-coding RNA。
▍Morpholino介绍
Morpholino属于第三代反义寡核苷酸，主要通过阻断蛋白质翻译过程而达到抑制目标基因功能的作用，目前已经广泛用于发育生物学和细胞学实验中，并取得了非常好的实验效果。
Morpholino以吗啉环类似物为基本骨架，这种独特的结构特性使得Morpholino 具有以下几个特点：
● 与其他类型的反义寡核苷酸相比，Morpholino 能更好地抵抗核酸酶的作用；
● Morpholino 与靶序列结合后通过空间位阻效应发挥作用， 不激活RNaseH，不引起目标基因mRNA 的降解 ；
● 针对翻译起始位点区设计的Morpholino 用于抑制蛋白质的翻译，针对 pre-mRNA 剪切位点区设计的Morpholino 可影响mRNA 剪切，得到不 同的转录本，可以方便地用于目标基因结构域的突变研究；
● 与靶序列结合能力强，可以渗入mRNA 的二级结构， 并且特异性好。
配合Morpholino 的使用，Gene Tools公司开发了相应的递送系统，可以安全、高效地将Morpholino 输送至胞内，因此，Morpholino 也可以用于遗传学研究和新药靶标的发现以及验证。此外，Morpholino 可以标上荧光基团、亲和标签以及活性反应基团，以供不同的研究需要。
▍Gene Tools公司产品介绍
● Custom Morpholino：可以根据目标基因序列定制设计并合成Morpholino，用于体外细胞实验或某些直接显微注射的模型（如斑马鱼、非洲爪蟾胚胎）。
● Vivo-Morpholino：适用于活体动物模型（小鼠，大鼠，狗，灵长类等），细胞培养，器官培养等。通过特殊的末端修饰，提高了其穿透细胞膜进入组织细胞的能力，使得在成年动物（主要是小鼠、大鼠）中进行系统性基因功能研究成为可能。
● Prepared Control Oligos：根据特定需求合成细胞穿透肽偶联的 Morpholino。适用于活体动物模型（小鼠，大鼠，狗，灵长类等），细胞培养，器官培养等。
| 产品名称 | Short Description | Oligo sequence | SKU |
| Standard Control Oligo | Negative control oligo | CCTCTTACCTCAGTTACAATTTATA | PCO-StandardControl-100 |
| Vivo-Morpholino Standard Control Oligo | Negative Vivo-Morpholino control oligo | CCTCTTACCTCAGTTACAATTTATA | PCO-VivoStandardControl-100 |
| Random Control Oligo 25-N | 25-base random sequence mixture | NNNNNNNNNNNNNNNNNNNNNNNNN | PCO-RandomControl-25N-100 |
| Zebrafish p53 oligo | Danio rerio apoptosis suppression oligo | GCGCCATTGCTTTGCAAGAATTG | PCO-ZebrafishP53-100 |
| Zebrafish Chordin Positive Control Oligo | Danio rerio Chordin positive control oligo | ATCCACAGCAGCCCCTCCATCATCC | PCO-ZebrafishChordin-100-F |
| Clawed Frog Beta Catenin Positive Control Oligo | Xenopus laevis Beta Catenin antisense oligo | TTTCAACCGTTTCCAAAGAACCAGG | PCO-BetaCatenin-100-F |
| Green Fluorescent Protein Positive Control | Translation blocker for GFP target | ACAGCTCCTCGCCCTTGCTCACCAT | PCO-GFPControl-100 |
| Vivo-Morpholino GFP Positive Control | Translation blocker for GFP target (Vivo-Morpholino) | ACAGCTCCTCGCCCTTGCTCACCAT | PCO-VivoGFPControl-100 |
| Fluoresceinated Vivo-Morpholino Std Control | Negative Vivo-Morpholino control oligo with 5'Fluorescein | CCTCTTACCTCAGTTACAATTTATA | PCO-FluorVivoStandardControl-100-F |
● Endo-Porter：为了解决Morpholino在体外培养细胞中摄取效率低的问题，Gene Tools 开发了 Endo-Porter 这种特殊的转染试剂。它通过温和的内吞体逃逸机制帮助Morpholino进入细胞质。
<Nanostructured & Amorphous Materials, Inc.致力于纳米材料科技的应用。主要的业务包括：生产、研发、加工纳米级和非结晶材料。
Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. We are a leading nanomaterials company involved in all aspects of the business: manufacturing, research and development, processing, supplying and marketing of nanostructured materials and their dispersions.
Nanostructured & Amorphous Materials的主要产品包括：
Application-Oriented Carbon-Nanotubes Products
Carbon Nanotubes & Nanofibers
Carbon Nanotube Dispersions
Elements, Oxides, Carbides & Nitrides Nanoparticles
Fullerene
Graphenes, Graphene Oxides & Graphene Nanoplatelets
Graphene Film
Nanopowder Dispersions
Nanowires & Nanorods
Amorphous Ribbons
Nanocrystalline Ribbons
Amorphous & Nanocrystalline Cores
Amorphous and Nanocrystalline Magnetic Bars
Amorphous & Nanocrystalline Powders
Amorphous Brazing Foils
Superhard Materials
Surface-Modified Oxide Nanoparticles
| 品名 | 货号 | 规格 |
| CNTs Additives for Lithium-ion Battery | 1376YJ | 1kg; |
| Carbon Nanotubes Fibers | 1356YJ | meter; |
| Carbon Nanotubes Papers | 1348YJ | piece; |
| Carbon Nanotubes Films | 1350YJ | piece; |
| Carbon Nanotubes Films | 1351YJ | 咨询 |
| Water-based carbon nanotubes coatings | 1332YJ | kg; |
| Water-based carbon nanotubes coatings | 1333YJ | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJA | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJB | kg; |
| Conductive/heating carbon-nanotubes coatings | 1378YJA | kg; |
| 20wt% CNTs/80wt% ABS Masterbatch | 1335YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HDPE Masterbatch | 1337YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HIPS Masterbatch | 1338YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% LLDPE Masterbatch | 1339YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PA6 Masterbatch | 1340YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PP Masterbatch | 1341YJ | 1kg; 5kg; 10kg; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Dispersion | 8040YJ | 500g; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Dispersion | 8042YJ | 500g; |
| 2 wt% MWCNTs (> 98%, D 5-15 nm)/Water Dispersion | 8028YJ | 500ml; |
| 2 wt% MWCNTs-COOH (> 98%, D 5-15 nm)/Water Dispersion | 8027YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/Water Dispersion | 8030YJ | 500 ml; |
| 10 wt% MWCNTs-COOH (>98%, D 30-80 nm)/Water Dispersion | 8029YJ | 500 ml; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Paste | 8038YJ | kg; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Paste | 8039YJ | 500g; kg; |
| 2 wt% MWCNTs (> 95%, D 5-15 nm)/Water Paste | 8032YJ | kg; |
| 2 wt% MWCNTs-COOH (> 95%, D 5-15 nm)/Water Paste | 8033YJ | kg; |
| 10 wt% MWCNTs (> 95%, D 30-80 nm)/Water Slurry | 8034YJ | kg; |
| 10 wt% MWCNTs-COOH (> 95%, D 30-80 nm)/Water Paste | 8035YJ | kg; |
| 12-14 wt% MWCNTs (> 95%, D 30-80 nm)/Water Paste | 8036YJ | kg; |
| 12-14 wt% MWCNTs-COOH (>95%, D 30-80 nm)/Water Paste | 8037YJ | kg; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/BA Dispersion | 8116YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMAC Dispersion | 8118YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMF Dispersion | 8115YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/IPA Dispersion | 8117YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/NMP Dispersion | 8114YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/BA Dispersion | 8124YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/BA Dispersion | 8123YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMAC Dispersion | 8126YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMAC Dispersion | 8125YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMF Dispersion | 8122YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMF Dispersion | 8121YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/IPA Dispersion | 8130YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/IPA Dispersion | 8129YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/NMP Dispersion | 8120YJ | 500 ml; |
| 5 wt% MWCNTs (> 98%, D 30-80 nm)/NMP Dispersion | 8119YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/PMA Dispersion | 8128YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/PMA Dispersion | 8127YJ | 500 ml; |
| Fullerence powder (C60, 95+%) | 8072YJ | 1g; 5g; |
| Fullerence powder (C60, 98+%) | 8073YJ | 1g; 5g; |
| Fullerence powder (C60, 99+%) | 8074YJ | 1g; 5g; |
| Fullerene powder (C60, 99.5+%) | 8075YJ | 1g; 5g; |
| Fullerene powder (C60, 99.9+%) | 8076YJ | 1g; 5g; |
| Fullerence powder (C70, 95+%) | 8077YJ | 1g; 5g; |
| Fullerence powder (C70, 98+%) | 8078YJ | 1g; 5g; |
| Fullerence powder (C70, 99+%) | 8079YJ | 1g; 5g; |
| Fullerenol Powder (hydroxylated fullerence C60) | 8080YJ | 1g; 10g; |
| Three-Dimensional Graphene (> 60 wt%, D 6-8 um, 3-4 layers) | 8109YJ | 1g; 5g; |
| 1.0-1.5 wt% Graphenes (> 98 wt%, Dia. 4-6 um, < 10 layers)/NMP paste | 8064YJ | 1g (graphene); 5g (graphene); |
| Highly Elastic Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8095YJ | 1 cylinder; 5 cylinders; |
| Ultra-light Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8093YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 1.2 cm, Height 1.2 cm) | 8090YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8091YJ | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8096YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8096YJB | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8097YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8097YJB | 1 cylinder; 5 cylinders; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam (nickel foam etched, thickness 1-1.2 mm) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| 1-3 wt% Graphene Oxide (> 98 wt%, D 1-5 um, 1-2 layers)/Water Gel, pH = 3-4 | 8047YJB34 | 1g (graphene oxide); 5g (graphene oxide); |
| Graphene Oxide Paper (Dia. 9 cm, thickness 10 um) | 8089YJ | 1 piece; 5 pieces; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-13 um, < 30 layers) | 8055YJ2 | 50g; 250g; 1kg; |
| 5 wt% Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers)/NMP Paste | 8059YJ | kg (paste); |
| Industrial-Grade Graphene-Nanoplatelets/Carbon-Nanotubes Composites (> 90 wt%) | 8071YJ | 50g; 100g; |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/Water Paste | 8060YJ | kg (paste); |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/NMP Paste | 8061YJ | kg (paste); |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Silver Nanopowder (Ag, 99.9+%, 20 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7031HW | 500ml; 1L; |
| Silver Nanopowder (Ag, 99.9+%, 50 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7033HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 100 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7035HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 200 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7038HW | 500ml; |
| Gold Nanopowder (Au, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7041HW | 500ml; |
| Platinum Nanopowder (Pt, 99.9+%, 20-30nm) 0.1wt% Dispersion in Water | 0488HW | 500ml; |
| Palladium Nanopowder (Pd, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7051HW | 500ml; |
| Palladium Nanopowder (Pd, 99.9+%, 10 nm) 0.1wt% Dispersion in Water | 0466HW | kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) Dispersed in 850ml of Ethanol | 0388HW | 咨询 |
| Aluminum Oxide (alpha, 20 wt%, 30-60nm) in Water | 7017WJWA | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 30 nm) in Water | 7017WJWG | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 10 nm) in water | 7016WJWG | 1kg; |
| CuO, 1 wt%, in water, APS 30 nm | 9019WJ | kg; |
| Silicon Oxide (15 wt%, 30 nm) in water | 7019WJ | 30kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7015WJ | 1kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7016WJ | 1kg; 10kg; |
| Titanium Oxide (Rutile, 40 wt%, 30-50 nm) in water | 7013WJWR | 1kg; |
| Titanium oxide TiO2 (40wt%, Rutile, 30-50 nm ) in Isopropanol | 5006WJ | kg; |
| Titanium Oxide (TiO2, Rutile, >99.5%, 5-30 nm,15 wt%) in water | 7012WJWR | 1kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in IPA | 7014WJWA | 1kg; |
| Titanium Oxide (Anatase, ATO doped, 20 wt%, 15-25 nm) Slurry | 7030WJ | 5kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in water | 7012WJWA | 1kg; |
| Titanium Oxide (Anatase, 15 wt%, 5-30 nm) in water | 7011WJWA | 1kg; |
| Titanium Oxide (TiO2, Anatase, >99.5%, 15 nm, 15 wt%) in water, negatively charged | 7011WJWANC | 咨询 |
| Titanium Oxide Nanopowder (anatase, 5 wt%, 10-20 nm) in ethanol | 7019HT | 1L; 5L; |
| Zinc Oxide (20 wt%, 40 nm) in water | 7006WJ | 1L |
| Indium Tin Oxide (ITO, 30 wt%, 20-30 nm) in Water | 7026HZW | 100g; |
| Silver nanowires (Dia. 70 - 80 nm, Length > 10 um) | 0475HW6 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (Dia. 30 - 50 nm, Length > 10 um) | 0475HW5 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver Nanowires (Dia. 20 - 30 nm, Length > 10 um) | 0475HW4 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW2E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW2I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW2W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW3E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW3I | 1 g (Ag nanowires); 2 g (Ag nanowires); 3 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in water) | 0475NW3W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW5E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW5I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in water) | 0475NW5W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW6E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW6I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW6W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Single-walled Carbon nanotubes - 60%SWNTs (90%CNTs) | 1283YJ | 1g; 5g; |
| SWNT-OH (90% CNTs, 60% SWNTs) | 1285YJF | 1g; 5g; |
| SWNT-COOH (90% CNTs, 60% SWNTs) | 1287YJF | 1g; 5g; |
| Short SWNTs (90% CNTs, 60% SWNTs) | 1281YJS | 1g; 5g; |
| SWNT-OH (> 60%, OD 1-2 nm, Length 1-3 um) | 1285YJFS | 1g; |
| SWNT-COOH (> 60%, OD 1-2 nm, Length 1-3 um) | 1287YJFS | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | g; |
| Single-walled carbon nanotubes - 90%SWNTs (95%CNTs) | 1284YJ | g; 5g; |
| SWNT-OH (95% CNTs, 90% SWNTs) | 1286YJF | 1g; |
| SWNT-COOH (95% CNTs, 90% SWNTs) | 1288YJF | 1g; |
| SWCNTs (> 90%, OD 1-2 nm, Length 1-3 um) | 1246YJS | 1g; 5g; |
| Single-Walled Carbon Nanotubes (90+%), -OH Functionalized | 1586YJF | 1g; |
| Single-Walled Carbon Nanotubes (90+%), -COOH Functionalized | 1588YJF | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | 1g; |
| High-Purity SWNTs, -OH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1368YJF | 1g; |
| High-Purity SWNTs, -COOH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1369YJF | 1g; |
| High-Purity Short SWNTs (> 95%, OD 1-2 nm, Length 1-3 um) | 1372YJ | 1g; |
| High-Purity Short SWNTs, -OH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1373YJF | 1g; |
| High-Purity Short SWNTs, -COOH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1374YJF | 1g; |
| High-Purity SWNTs (> 95%), -NH2 functionalized | 1370YJF | 1g; 5g; |
| High-Purity Short SWNTs (> 95%), -NH2 functionalized | 1371YJFS | 1g; 5g; |
| High-Purity SWNTs (> 95 %, surface area > 1,075 m2/g) | 1300YJ | 1g; |
| DWNTs (> 60%, OD 2-4 nm, Length ~50 um) | 1280YJD | 1g; 5g; 25g; |
| DWNTs-COOH (> 60%, OD 2-4 nm, Length ~50 um) | 1281YJD | g; |
| Multi-Walled Carbon Nanotube -MWNT (98%, OD 4-6 nm) | 1389YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98%, OD 5-15 nm) | 1203YJ | 10g; 25g; |
| Multi-walled carbon nanotube -MWNT (99%, OD 5-15 nm) | 8101YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (95+%, OD 8-15 nm) | 1204YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 10-20 nm) | 1205YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 20-30 nm) | 1229YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98+%, OD 30-50 nm) | 1231YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 30-80 nm) | 1233YJ | 10g; 25g; |
| Short MWNT (98+%, OD 4-6 nm, Length 0.5-2 um) | 1392YJS | 5g; |
| Short MWNT (98+%, OD 5-15 nm, Length 0.5-2 um) | 1225YJS | 5g; |
| Short MWNT (99+%, OD 5-15 nm, Length 0.5-2 um) | 8104YJS | 5g; |
| Short MWNT (95+%, OD 8-15 nm, Length 0.5-2 um) | 1235YJS | 5g; |
| Short MWNT (>98%, OD 10-20 nm, Length 0.5-2 um) | 1236YJS | 10g; |
| Short MWNT (98+%, OD 20-30 nm, Length 0.5-2 um) | 1237YJS | 5g; |
| Short MWNT (98+%, OD 30-50 nm, Length 0.5-2 um) | 1238YJS | 5g; |
| Short MWNT (98+%, OD 30-80 nm, Length 0.5-2 um) | 1227YJS | 5g; |
| Graphitized MWNT (99.9%, OD 8-15 nm) | 1219YJ | 10g; 25g; |
| Graphitized MWNT (99.9%, OD 10-20 nm) | 1220YJ | 10g; |
| Graphitized MWNT (99.9%, OD 20-30 nm) | 1221YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-50 nm) | 1222YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-80 nm) | 1223YJ | 5g; |
| Industrial-grade MWNT (95+%, OD 4-6 nm) | 1395YJ | 1kg; |
| Industrial-Grade MWNT (95+%, OD 5-15 nm) | 1201YJG | 1kg; |
| Industrial-grade MWNT (95%, OD 8-15 nm) | 1201YJA | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-20 nm) | 1201YJB | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-30 nm) | 1201YJC | 1kg; |
| Industrial-grade MWNT (95+%, OD 20-40 nm) | 1201YJD | 1kg; |
| Industrial-Grade MWNT (95+%, OD 30-80 nm) | 1201YJE | 1kg; |
| MWNT-OH (98+%, OD 4-6 nm) | 1390YJF | 10g; |
| MWNT-OH (98+%, OD 5-15 nm) | 1261YJF | 5g; |
| MWNT-OH (99+%, OD 5-15 nm) | 8103YJF | 5g; |
| MWNT-OH (95+%, OD 8-15 nm) | 1262YJF | 5g; |
| MWNT-OH (98+%, OD 10-20 nm) | 1263YJF | 5g; |
| MWNT-OH (98+%, OD 20-30 nm) | 1264YJF | 5g; 25g; 100g; |
| MWNT-OH (98+%, OD 30-50 nm) | 1265YJF | 5g; |
| MWNT-OH (98+%, OD 30-80 nm) | 1266YJF | 5g; |
| Short MWNT-OH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1393YJF | 5 g; 100 g; |
| Short MWNT-OH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1247YJF | 5g; |
| Short MWNT-OH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8106YJF | 5g; |
| Short MWNT-OH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1248YJF | 5g; |
| Short MWNT-OH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1249YJF | 5g; |
| Short MWNT-OH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1251YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1252YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1253YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 8-15 nm) | 1224YJF | 1g; |
| Graphitized MWNT-OH (99.9%, OD 10-20 nm) | 1228YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 20-30 nm) | 1235YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-50 nm) | 1239YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-80 nm) | 1240YJF | 1g; 5g; |
| Industrial-grade MWNT-OH (95+%, OD 5-15 nm) | 1201YJI | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 8-15 nm) | 1201YJL | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 10-30 nm) | 1207YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 20-40 nm) | 1208YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 30-80 nm) | 1209YJF | 1kg; |
| MWNT-COOH (98+%, OD 4-6 nm) | 1391YJF | 10g; |
| MWNT-COOH (98+%, OD 5-15 nm) | 1267YJF | 5g; |
| MWNT-COOH (99+%, OD 5-15 nm) | 8102YJF | 10g; |
| MWNT-COOH (95+%, OD 8-15 nm) | 1268YJF | 5g; |
| MWNT-COOH (98+%, OD 10-20 nm) | 1269YJF | 5g; |
| MWNT-COOH (98+%, OD 20-30 nm) | 1270YJF | 5g; |
| MWNT-COOH (98+%, OD 30-50 nm) | 1271YJF | 5g; |
| MWNT-COOH (98+%, OD 30-80 nm) | 1272YJF | 5g; |
| Short MWNT-COOH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1394YJF | 5g; |
| Short MWNT-COOH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1254YJF | 5g; |
| Short MWNT-COOH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8105YJF | 5g; |
| Short MWNT-COOH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1255YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1256YJF | 5g; |
| Short MWNT-COOH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1257YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1259YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1273YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 8-15 nm) | 1241YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 10-20 nm) | 1242YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 20-30 nm) | 1243YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 30-50 nm) | 1244YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 30-80 nm) | 1245YJF | 1g; 5g; |
| Industrial-grade MWNT-COOH (95+%, OD 5-15 nm) | 1201YJH | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 8-15 nm) | 1201YJK | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 10-30 nm) | 1210YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 20-40 nm) | 1216YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 30-80 nm) | 1218YJF | 1kg; |
| Aligned MWNT (98+%, OD 8-15 nm, Length: 30-50 um) | 1215YJA | 25g; |
| Carbon nanofibers (70+%, D = 200-600 nm, L = 5-50 um) | 1177YJ | 10g; |
| Carbon Nanofibers (95+%, D = 50-200 nm, L = 1-15 um) | 8107YJ | 10g; |
| Graphitized carbon nanofibers (95+%, OD = 50-200 nm, L = 1-15 um) | 1178YJ | 10g; |
| Graphene (> 98 wt%, D > 50 um, < 3 layers) | 2191YJ | 1g; 5g; |
| Graphene Oxide (> 99 wt%, D 0.5-3 um, < 3 Layers) | 2192YJ | 1g; 5g; |
| Graphene Nanoplatelets (> 99.5 wt%, D 5-10 um, < 20 layers) | 8056YJ | 1g; 5g; 25g; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers) | 8055YJ | 50g; 250g; 1kg; |
| *60% Ni/38% MWNT (95+%, OD 8-15 nm) | 1293YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 10-20 nm) | 1294YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 20-30 nm) | 1295YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-50 nm) | 1296YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-80 nm) | 1297YJ | 10g; |
| MWNT-NH2 (95+%, OD 8-15 nm, 0.45 wt% amino) | 1562YJF | 5g; |
| Nitrogen-doped MWNTs (98%, OD 30-80 nm) | 8054YJ | 5g; |
| Large inner diameter thin-walled multi-walled carbon nanotubes | 1563YJF | 5g; |
| Coiled CNTs (60+%, OD 100-200 nm, Length 1-10 um) | 1298YJ | 5g; |
| Silver Nanopowder (Ag, 99.99%, 400 nm ) | 0487HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 200 nm ) | 0479HW | 咨询 |
| Silver Nanopowder (Ag, 99.99%, 100 nm ) | 0489HW | 咨询 |
| Silver Nanopowder (Ag, 99%, 90-210 nm) | 0471CD | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm ) | 0475HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm, w/~0.3% PVP ) | 0476HW | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 40 nm ) | 0473HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 40 nm, w/~0.3% PVP ) | 0474HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 30-50 nm, w/0.2 wt% PVP) | 0477YD | 咨询 |
| Silver Nanopowder (Ag, 35 nm, 99.5%, metal basis) | 0476JY | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 20 nm ) | 0477HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 20 nm, w/~0.3% PVP ) | 0478HW | 咨询 |
| Aluminum Powder (99.9%, 500 um) | 0156HW | 咨询 |
| Aluminum Powder (99.9%, 50 um) | 0154HW | 咨询 |
| Aluminum Powder (99.9%, 5 um) | 0152HW | 咨询 |
| Aluminum Nanoparticles (99.9%, 500 nm) | 0150HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 70-80 nm) | 0137HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 70-80 nm, w/PVP) | 0140HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 40-50 nm) | 0138HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 40-50 nm, w/PVP) | 0139HW | 咨询 |
| Aluminum Nanopowder (Al, 99+%, metal basis, 18 nm) | 0136JY | 咨询 |
| Gold (Au) Nanopowder (99.9%, 50-100 nm) | 0795CD | 咨询 |
| Gold (Au) Nanopowder (25nm, 99.9%) | 8801HW | 咨询 |
| Gold (Au) Nanopowder (10-20 nm, 99.95%) | 8796HW | 咨询 |
| Gold (Au) Nanopowder (10nm, 99.9%) | 8799HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.9%, 80-100 nm) | 0832HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.5%, 40-60 nm) | 0831HW | 咨询 |
| Nano Activated Carbon (C, 88+%, 100 nm) | 1211NH | 咨询 |
| Diamond Nanopowder (synthesized, 55-70%, 4-15nm) | 1311JGY | 咨询 |
| Diamond Nanopowder (synthesized, 98+%, 3-10 nm) | 1321JGY | 咨询 |
| Diamond Nanopowder (synthesized, 97%, 3-6 nm) | 1350SL | 咨询 |
| Graphite Nanopowder (400 nm, 99.9%) | 1250HT | 咨询 |
| *Cobalt Nanopowder, Carbon Coated (Co, 99%, 40 nm) | 0286HW | 咨询 |
| *Cobalt Nanopowder (Passivated, 99.8%, 28 nm) | 0276JY | 咨询 |
| *Chromium Nanopowder (Cr, 99.5%, 50 nm) | 0240XX | 咨询 |
| *Copper Nanopowder (Cu, 99%, 500 nm) | 0293HW | 100g; |
| *Copper Nanopowder (Cu, 99.9%, 200 nm) | 0290HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 100 nm) | 0298HW | 25g; |
| *Copper Nanopowder (Partially Passivated, 99+%, 80 nm) | 0294HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 70 nm) | 0291HW | 25g; |
| *Copper Nanopowder (Cu, 99.5%, 50-80 nm) | 0292HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 40 nm) | 0295HW | 25g; |
| *Copper Nanopowder (Cu, carbon coated, 99.8%, 25 nm) | 0297JY | 5g; |
| *Iron Nanopowder (Fe, 99.9%, 500nm) | 0272YM | 100g; 1kg; |
| *Iron Nanopowder (Fe, 99.9%, 100 nm) | 0264HW | 25g; |
| *Iron Nanopowder (Fe, 99.9%, 70 nm) | 0263HW | 25g; 100g; |
| *Iron Nanopowder (Fe, 99.9%, 40 nm) | 0262HW | 25g; 100g; |
| *Iron nanopowder, carbon coated (Fe/C, 99.6%, 25 nm) | 0267JY | 25g; |
| Germanium Nanopowder (Ge, 99.9+%, 600 nm) | 0327HW | 25g; |
| Germanium Nanopowder (Ge, 99.9%, 500 nm) | 0331HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) | 0326HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 300 nm) | 0325HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 200 nm) | 0323HW | 100g; kg; |
| Germanium Nanopowder (Ge, 99.9+%, 150 nm) | 0322HW | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, < 100 nm) | 0322HH | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, 20-50 nm) | 0321HW | 5g; |
| Iridium Nanopowder (Ir, 99.95%, 20-30 nm), wet powder in Deionized Water | 0771HW | 咨询 |
| *Molybdenum Nanopowder (Mo, 99.5%, 70 nm) | 0423HW | 咨询 |
| Niobium Nanopowder (Nb, 99.9%, 40-60 nm) | 0411HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 800 nm) | 0302HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 400 nm) | 0301HW | 100g; 1kg; |
| *Nickel Nanopowder (Ni, 99+%, 300 nm) | 0289HW | 1kg; |
| *Nickel Nanopowder (Ni, 99.5%, 100 nm) | 0285HW | 25g; |
| *Nickel Nanopowder (Ni, 99.9%, 80 nm) | 0284HW | 300g; |
| *Nickel Nanopowder (Ni, 99.5%, 70 nm) | 0288HW | 25g; |
| *Nickel Nanopowder (Ni, 99.5%, 40 nm) | 0283HW | 25g; |
| *Nickel Nanopowder, carbon coated (Ni/C, 99.9%, 20 nm) | 0287JY | 5g; |
| Palladium Nanopowder (Pd, 99.95%, 20-30 nm) | 0462HW | 咨询 |
| Platinum Nanopowder (Pt, 99.95%, 20-30 nm) | 0782HW | 咨询 |
| Platinum Nanopowder, PVP coated (Pt, 99.95%, 20-30 nm) | 0787HW | 1g; |
| Platinum Nanopowder (Pt, 99.9%, 20-30 nm) | 0786HW | 1g; 5g; |
| Rhodium Nanopowder (Rh, 99.95%, 20-30 nm) | 0451HW | 咨询 |
| Ruthenium Nanopowder (Ru, 99.95%, 20-30 nm) | 0441HW | 1g; |
| *Silicon Nanopowder (Si, 99%, 400 nm) | 0144HW | 100g; |
| *Silicon Nanopowder (Si, 99.9%, 100 nm) | 0149HW | 100g; |
| *Silicon Nanopowder (Si, > 97%, 50 nm) | 0145KE | 咨询 |
| *Silicon Nanopowder (Si, 99%, 30-50 nm) | 0147HW | 50g; |
| *Silicon Nanopowder (Si, 98+%, 30-50 nm) | 0141JS | 50g; 100g; 500g; 1kg; |
| Tin Nanopowder (Sn, 70 nm, w/PVP ) | 5522HW | 500g; |
| Tin Nanopowder (Sn, 99.9%, 60-80 nm) | 0501HW | 咨询 |
| *Tantalum Nanopowder (Ta, 99.9%, 40 nm) | 0225HW | 25g; |
| *Tantalum Nanopowder (Ta, 99.9%, 70 nm) | 0224HW | 25g; |
| *Titanium Nanopowder (Ti, 99%, 60-80 nm) | 0227HW | 25g / $361; |
| *Tungsten Powder (W, 99.5+%, 1-2 um) | 0747HW | 100g; |
| *Tungsten Nanopowder (W, 99.5%, 500 nm) | 0749HW | 1kg; |
| *Tungsten Nanopowder (W, 99.5%, <100 nm) | 0745HW | 100g; |
| *Zinc Nanopowder (Zn, 99%, 500 nm) | 0318HW | 1kg; |
| *Zinc Nanopowder (Zn, 99.5%, 130 nm) | 0303HW | 25g; |
| *Zinc Nanopowder (Zn, 99.9+%, 100 nm) | 0306JY | 25g; |
| *Zinc Nanopowder (Zn, 99.5%, 80 nm) | 0304HW | 25g; |
| *Aluminum Nitride Nanopowder (AlN, Amorphous, <0.5um, 99.9%) | 1004HW | 咨询 |
| Aluminum Nitride Nanopowder (AlN, 99.9 %, 0.5 um) | 1005HW | 咨询 |
| *Aluminum Nitride Nanopowder (AlN, 99.5 %, 70-80 nm) | 1002HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 500 μm) | 1175HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 50 μm) | 1177HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 40 μm) | 1179HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 20μm) | 1172HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 10μm) | 1169HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 5 μm) | 1165HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 2 um) | 1183HW | 1 kg; |
| Boron Carbide Powder (B4C, 99+%, 1-2 μm) | 1162HW | 咨询 |
| Boron Carbide Nanopowder (B4C, 99+%, 500 nm) | 1160HW | 500g; |
| Boron Carbide Nanopowder (B4C, 99%, 50nm) | 1161HY | 100g; |
| Boron Nitride Powder (BN, hexagonal, 99.8%, 0.6-1.2um) | 1182HW | 咨询 |
| Boron Nitride Nanopowder (BN, hexagonal, 99%, 137 nm) | 1180YL | 25g; |
| Boron Nitride Nanoplates (BN, 99.5+%, 100 nm) | 1183NJ | 100g; |
| Chromium Carbide Nanopowder (Cr3C2, 99.9%, <100 nm) | 0247HW | 500g; 1kg; |
| Hafnium Boride Nanopowder (HfB2, 99+%, 60 nm) | 1010JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 200 nm) | 1005JC | 500g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 60 nm) | 1006JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99%, 50nm) | 1022JC | kg; |
| Niobium Carbide Nanopowder (NbC, 99.9%, 500 nm) | 3860YM | 咨询 |
| Silicon Carbide Powder (SiC, 500 um, 99%, Hexagonal) | 4652HW | 1kg; ; |
| Silicon Carbide Powder (SiC, 50 um, 99%, Hexagonal) | 4654HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 40um, 99+%) | 4645HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 20um, 99+%) | 4643HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 10um, 99+%) | 4641HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 7um, 99+%) | 4639HW | 100g; 1kg; ; |
| Silicon Carbide Powder (SiC, beta, 99.8%, 5 μm) | 4637HW | 100g; ; |
| Silicon Carbide Powder (SiC, beta, 99+%, 2 μm) | 4635HW | 咨询 |
| Silicon Carbide Powder (SiC, alpha, 99.9%, 2um) | 4627HY | 1kg; |
| Silicon Carbide Powder (SiC, 500 nm, 99%, Cubic) | 4656HW | 1kg; ; |
| Silicon Carbide Nanopowder (SiC, beta, 99%, 80-100 nm) | Stock # 4629HW | 100g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 55 nm) | 4625HY | 100g; |
| Silicon Carbide Nanopowder (SiC, beta, 97.5%, 45-55 nm) | 4620KE | 200g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 30 nm) | 4626HY | 100 g; 150 g; |
| Silicon Carbide Nanowhisker (beta, SiC, 99+%) | 4622HW | 25g; |
| Silicon Nitride Nanopowder (Si3N4, amorphous, 98.5+%, 15-30 nm) | 4750KE | 100g; |
| Titanium Boride Powder (TiB2, 2-12 μm ) | 5180HW | 100g |
| *Titanium Carbide Powder (TiC, 1 micron, 99%) | 5218YL | 500g; |
| *Titanium Carbide Nanoparticles (TiC, 100-200nm, 99+%) | 5217HW | 1kg; |
| Titanium Carbide (TiC, 99+%, 100 nm) | 5217JC | 100g; |
| *Titanium Carbide (TiC, 98+%, 80 nm) | 5220HT | 25g; 100g; |
| *Titanium Carbide Nanopowder (TiC, 97+%, 50 nm) | 5216KE | 100g; |
| *Titanium Nitride Powder (TiN, 99%, 1-3um) | 5352JC | 500g; 1kg; |
| *Titanium Nitride Nanoparticles (TiN, 99%, 100-200 nm) | 5357HW | 500g; |
| *Titanium Nitride Nanopowder (TiN, 97+%, 20 nm) | 5350KE | 100g; |
| Tungsten Carbide/Cobalt Nanopowder (8wt%Co/WC, < 200 nm, 99.5%) | 5561HW | 100g |
| Zirconium Carbide Nanopowder (ZrC, 99%, 8 um) | 5905KE | 100g; 250g; 500g; |
| *Zirconium Carbide Nanopowder (ZrC, 97%, 60 nm) | 5901KE | 100g; |
| *Zirconium Nitride Nanopowder (ZrN, 99.5%, 1-3um) | 6101JC | 500g; kg; |
| Zirconium Boride Nanopowder (ZrB2, 99%, 60 nm) | 5950JC | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 500 nm) | 1037HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99+%, 500 nm) | 1038HT | 100g; |
| Aluminum Oxide Nanopowder (alpha, aluminate coated, 98+%, 500 nm) | 1039HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 200 nm) | Stock #:1040LQS | 100g |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 150 nm) | 1005MR | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 40-50 nm) | 1044HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha/theta, 99.99%, ~30nm ) | 1018WJ | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99+%, 500 nm) | 1045HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.97%, 20-30 nm) | 1020MR | 100g; 500g; 1kg; |
| Aluminum Oxide Nanopowder (gamma, 99.5%, 50 nm) | 1007XX | 咨询 |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.99%, 10 nm) | 1043HT | 100g; |
| Aluminum oxide nanopowder, (γ-phase) APS 20-30 nm, 99.95+% | 0125HW | 咨询 |
| Aluminum Oxide Nanopowder ( 99.99%, 30 nm ) for Lithium Batteries | 1016WJ | 咨询 |
| Aluminum Hydroxide Nanopowder (99.5 %, 50 nm) | 1040WJ | 咨询 |
| Boron Oxide Nanopowder (B2O3, 98%, 40-80 nm) | 1185DF | 咨询 |
| Boron Oxide Nanopowder (B2O3, 99%, 40-80 nm) | 1186DF | 1kg; |
| Bismuth Oxide Nanopowder (Bi2O3 , 99.9%, 100 nm) | 1171HT | kg; |
| Cerium Oxide, (CeO2, 99.99%, 200 nm) | 1445MG | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99%, 50-100 nm) | 1408HW | 100g; |
| Cerium Oxide (CeO2, 99.99%, 20-30 nm) | 1444ZQ | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99.9%, 15-30 nm) | 1406RE | 100g; |
| Cobalt(II,III) Oxide Nanopowder (Co3O4, 99%, 50-80 nm) | 1720HT | 咨询 |
| Chromium Oxide Powder (Cr2O3, 99.8%, 1 um) | 1920FY | 25g; 1kg; |
| Chromium Oxide Powder (Cr2O3, 99.9%, 100 nm) | 1925FY | 100g; 1kg; |
| Chromium Oxide Nanopowder (Cr2O3, 99+%, 60 nm) | 1910FY | 25g; |
| Copper(II) Oxide Nanopowder (CuO, 99+%, 30-50 nm) | 2110FY | 咨询 |
| Copper(I) Oxide Nanopowder (Cu2O, 99%, 30-50 nm) | 2113HW | 25g; 100g; 500g; 1kg; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 55 nm) | 2252YS | 25g; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 30-70 nm) | 2253ZQ | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 43 nm) | 2310ZQ | 65g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 41-53 nm) | 2350YS | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 20-30 nm) | 2330RE | 25g ; |
| Europium Oxide Nanopowder (Eu2O3, 99.995%, 58 nm) | 2410ZQ | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 45-58 nm) | 2450YS | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 30-50 nm) | 2411RE | 5g; |
| Iron(III) Oxide Nanopowder (Fe2O3, gamma, 99.98%, 50 nm) | 2527YM | 1kg |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30-50 nm) | 2520ZH | 25g; 100g; |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30 nm) | 2525WJ | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 100-200 nm) | 2653HW | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 97%, 50-100 nm) | 2650TS | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, SSA: 9-14 m2/g, 50-100 nm) | 2655HW | 100g; 500g; 1kg; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 30 nm) | 2651WJ | 100g; |
| Iron Oxide Nanopowder (Fe3O4, PVP coated, 99+%, 20-30 nm) | 2657HW | 100g; 1kg; |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9+%, 20-80 nm) | 2680ZQ | 咨询 |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9%, 15-30 nm) | 2681RE | 咨询 |
| Hafnium Oxide Powder (HfO2, 99.99%, 48um) | 1045HW | 咨询 |
| Hafnium Oxide Powder (HfO2, 99%, 45um) | 1042HW | 咨询 |
| Indium Oxide Nanopowder (In2O3, 99.99%, 100-200 nm) | 2711TN | 咨询 |
| Indium Hydroxide Nanopowder (In(OH)3, 99.99%, 20-70 nm) | 2810TN | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99%, 50 nm) | 2922RE | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99.99%, 15-30 nm) | 2920RE | 咨询 |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40-60 nm) | 3305HT | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 1kg; |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40 nm) | 3304HT | 咨询 |
| Magnesium Hydroxide Nanopowder (Mg(OH)2, 98+%, 100 nm) | 3321HT | 咨询 |
| Molybdenum(VI) Oxide Nanopowder (MoO3 , 99.5%, 100 nm) | 3851XW | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9+%, 83 nm) | 3910ZQ | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 49-64 nm) | 3950YS | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 15-30 nm) | 3911RE | 25g; |
| Nickel Oxide Nanopowder (Ni2O3, 99.9%, 20-30 nm) | 4216HW | 100g; |
| Praseodymium Oxide Nanopowder (Pr6O11, 99.9%, 15-30 nm) | 4451RE | 25g; |
| Antimony Oxide Nanoparticles (Sb2O3, 99.99%, 20-30nm) | 6850HW | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.99%, 1-3.5 μm) | 4856WG | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.998%, 1-3.5um) | 4855WG | 咨询 |
| Silicon Oxide Nanopowder (SiO2 , 99+%, 20 nm) | 4830HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4831HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4832HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4833HT | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 42-55 nm) | 4950YS | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 15-30 nm) | 4951RE | 咨询 |
| Titanium Oxide Nanopowder (TiO2, amorphous/anatase, 99+%, 5 nm) | 5416HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99%, 10-30 nm) | 5420HT | 咨询 |
| Titanium Oxide Nanopowder(TiO2, anatase, 99%,15 nm) | 5430MR | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99+%, 10 nm) | 5417HT | 咨询 |
| Titanium Oxide Nanopowder (tungsten oxide doped, TiO2/WO3, anatase, 10 nm) | 5418HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 5 nm) | 5421ZH | 咨询 |
| Titanium Oxide Nanotubes (TiO2, anatase, 99%, 10-15 nm) | 5432HW | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase/rutile, 99+%, 20 nm) | 5419HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 30 nm) | 5426HT | 咨询 |
| Titanium oxide (silica, alumina & stearic acid coated, anatase/rutile, 30 nm) | 5427HT | 咨询 |
| Titanium Oxide Nanopowder (silica, alumina & silicone oil coated, anatase/rutile, 30 nm) | 5428HT | 咨询 |
| Titanium oxide, silica coated (anatase/rutile, 20 nm) | 5422HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 20 nm) | 5423HT | 咨询 |
| Titanium oxide, silica & stearic acid coated (anatase/rutile, 20 nm) | 5424HT | 咨询 |
| Titanium oxide, silica & silicone oil coated (anatase/rutile, 20 nm) | 5425HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 500 nm) | 5429HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 150 nm) | 5430HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 100 nm) | 5431HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 60 nm) | 5486WJ | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 20-50 nm) | 5484WJ | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0302HT | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0301HT | 咨询 |
| Vanadium Oxide Nanopowder (VO2, 99.9+%, 100 - 200 nm) | 5495HW | 咨询 |
| 1.5% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5499HW | 咨询 |
| 1% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5498HW | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.5%, 60-120 nm) | 5508YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.9+%, 40-50 nm) | 5506BD | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm) | 5505YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm, PVP-coated) | 5506YL | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 50-70 nm) | 5610ZQ | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.99%, 20-40 nm) | 5611RE | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.9%, 32-36 nm) | 5650YS | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 20-40 nm) | 5611ZQ | 咨询 |
| Ytterbium Oxide Nanopowder (Yb2O3, 10-80 nm, 99.9%) | 5671RE | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99+%, 800 nm) | 5816HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 30 nm) | 5811HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, hydrophilic & lipophilic) | 5812HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, silicone oil coated) | 5814HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, stearic acid coated) | 5815HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 20 nm) | 5810HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99+%, 50 nm) | 5936HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99.5+%, 20 nm) | 5931HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/3 mol% Y2O3, 99.5+%, 15-50 nm) | 5932HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/5 mol% Y2O3, 99.5+%, 15-50 nm) | 5934HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/8 mol% Y2O3, 99.5+%, 15-50 nm) | 5933HT | 咨询 |
| Zirconia Nanopowder, Calcia Doped (ZrO2/8 mol%CaO, 99.9%, 20-30 nm) | 5934ZS | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 400 nm) | 1146DY | 100g; |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 300 nm) | 1144DY | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.5%, 100-200 nm) | 1148DY | 咨询 |
| Cobalt Iron Oxides Nanopowder (CoFe2O4, 98%, 35-55 nm) | 1510FY | 25g ; 100g; |
| Cobalt-Zinc Iron Oxide Nanopowder (Co0.5Zn0.5Fe2O4, 99.5%, 30-50 nm) | 1515FY | 25g ; 100g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 90wt%:10wt%, 99.99%, 20-70 nm) | 2730TN | 5g; 25g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 95 wt%:5 wt%, 99.99%, 30-50 nm) | 2731BY | 5g; 25g; |
| Nickel-Zinc Iron Oxide Nanopowder (Ni0.5Zn0.5Fe2O4, 98.5%, 10-30 nm) | 4115FY | 100g; 500g; |
| *Ni80Fe17Mo3 permalloy nanopowder (99+%, 70 nm) | 9288HW | 100g; |
| Yttrium Aluminate w/Nd doped (Y2.98Nd0.02Al5O12, Nd-YAG, 99.5%, 40 nm) | 5571FY | 25g; 100g; |
| Zinc Iron Oxide Nanopowder (ZnFe2O4, 98.5%, 40 nm) | 5710FY | 100g; |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
艾美捷科技代理Avanti Polar Lipids全系列产品。
Avanti Polar Lipids公司是美国著名的磷脂类产品的生产商，该公司主要为各种制药厂和研究机构提供从毫克级到公斤级乃至吨级的磷脂类和甾体类中间体和试剂。为世界范围内的研究机构和制药公司提供 1000 种以上脂类产品，由于其产品的高纯度而享誉全球。40年来，Avanti Polar Lipids公司为世界各地的研究人员和制药公司提供脂类产品。
Avanti Polar Lipids, Inc., has a long history of 50 years creating the highest purity lipids available. Our passion for high quality and unique products is only exceeded by our excellent reputation in the marketplace. Although we are known for our lipids, we are More than Lipids. We offer solutions for the entire product cycle…Research to Commercialization.
Avanti Polar Lipids公司的主要产品和服务包括：
（1）Research Products
Highest Purity Lipid Reagents
（2）cGMP Manufacturing
API & Contract Manufacturing
（3）Adjuvants
Immunotherapy & Vaccine Development
（4）Analytical Services
Lipid Analysis
（5）Lipidomics
Mass Spec Standards, Antibodies & Lipid Toolbox
（6）Formulations
Liposomes & Nanoparticles
（7）Equipment
Liposome Production Tools
（8）Custom Services
Synthesis & Beyond
" data-original="http://oz.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Avanti Polar Lipids"> Avanti Polar Lipids
Boston Biochem隶属于R&D System公司，是全世界最大的泛素相关产品的供应商。Boston Biochem生产的泛素产品包括蛋白、多肽、底物、小分子抑制剂、酶、蛋白酶体试剂盒交联试剂等。
Boston Biochem的主要产品包括：
Affinity Matrices / Proteins
Antibodies
Autophagy
Buffers
Deconjugating Enzymes
Deubiquitinating (DUBs)
E1 Activating
E2 Conjugating
E3 Ligase
Fractions
Heat Shock Proteins
Inhibitors
Kits
NEDD8
Other Ubiquitin-like
Proteasome
Substrate Proteins
SUMO & SUMOlyation
Ubiquitin
" data-original="http://oz.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Boston Biochem"> Boston Biochem
艾美捷科技代理Native Antigen Company品牌。
Native Antigen Company 是一家专注于生产和提供高质量天然抗原的公司。这些抗原广泛应用于疫苗开发、诊断试剂生产和免疫学研究。采用先进的生产和纯化技术，确保抗原的高纯度和高活性；抗原产品广泛应用于疫苗开发、诊断试剂和免疫学研究；提供灵活的定制抗原生产和开发服务，满足客户需求。Native Antigen Company 是传染病试剂主要供应商之一。
其主要产品与服务包括：
（1）天然抗原：提供多种天然抗原，包括病毒蛋白、细菌抗原和寄生虫抗原。
（2）重组蛋白：提供高质量的重组蛋白，用于研究和开发。
（3）诊断试剂：提供用于诊断试剂生产的抗原和抗体。
（4）定制服务：根据客户需求，提供定制化的抗原生产和开发服务。
PROGEN公司主要产品线：体外诊断领域中细胞生物学和生物医院学实验所需要的科研试剂盒抗体。核心产品主要为：K19抗体的衍生类产品和细胞胶蛋白类抗体等。
PROGEN is a specialist for premium immunochemicals since 1983. The company develops and manufactures test kits and reagents marketed as PROGEN products and is expanding its product portfolio on a continuous basis. The German Stifterverband has recognized PROGEN's research activities with the "Innovative through Research" award (2018).
Progen Biotech的主要产品包括：
（1）Antibodies
Adeno-Associated Virus (AAV) & M13
Cell cycle & apoptosis
Endocrinology
Immunology
Cytoskeleton & nuclear antigens
Cytoskeleton
Extracellular Matrix Proteins
Cell Membrane & Metabolism
Nuclear Antigens
Cytokeratins & hair keratins
Basic type II cytokeratin/ keratin K1-8
Acidic type I cytokeratin/ keratin K9-20
Cytokeratin/ keratin pan
Acidic type I hair keratin
Basic type II hair keratin
Inner root sheet keratin (irs)
Type I & II hair keratin pan
Lipid Metabolism
Microbiology
Nephrology
Neurobiology
Sperm Cell Proteins
Tumor biology
Adhesion, Junction & Desmosome Proteins
Secondary Antibodies
（2）Diagnostic Assays
Infectious Disease
Coagulation
Lipid Metabolism
（3）Phage Display
（4）AAV
（5）Antigens and Controls
（6）Density Gradient Media
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18327026838
传真：18995651644
邮箱：sales@amyjet.com
0.3095
